Case number 1:23-cv-00926
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 23, 2025 | 404 | TEXT ORDER - In light of the entry of the Stipulated Consent Judgment and Injunction (ECF No. 403), it is hereby ORDERED that the Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction (ECF No. 303) is DENIED AS MOOT. So Ordered by Judge Karen M. Williams on 6/23/2025. (dad) (Entered: 06/23/2025) (0) |
| Jun 20, 2025 | 402 | ANSWER to Counterclaim (Answer to the May 30, 2025 Counterclaims filed by Cipla Limited and Cipla USA Inc. in Civil Action No. 25-3790 at ECF No. 9) by All Plaintiffs.(CALMANN, ARNOLD) (Entered: 06/20/2025) (14) |
| Jun 20, 2025 | 403 | STIPULATION AND CONSENT JUDGMENT ORDER AND INJUNCTION. Signed by Judge Karen M. Williams on 6/20/2025. (sms2) (Entered: 06/20/2025) (3) |
| Jun 12, 2025 | 401 | TEXT ORDER Upon letter application dated June 11, 2025 from Arnold B. Calmann, Esquire, counsel for plaintiffs, and it appearing that all counsel consent to the request to schedule a Markman hearing, the Court hereby GRANTS the request. The Markman hearing is set for August 13, 2025 at 10:00 AM in Camden - Courtroom 4A. So Ordered by Judge Karen M. Williams on 6/12/25. (nar) (Entered: 06/12/2025) (0) |
| Jun 11, 2025 | 400 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Regarding Markman Hearing re 358 Letter. (CALMANN, ARNOLD) (Entered: 06/11/2025) (2) |
| Jun 9, 2025 | 395 | TEXT ORDER: By consent, the telephonic status conference and motion hearing on 6/11/2025 shall be, and is hereby, ADJOURNED. The Court has RESCHEDULED the telephonic status conference for 9/24/2025 at 2:00 P.M. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 749 623 882#. SO ORDERED by Magistrate Judge Ann Marie Donio on 6/9/2025. (slc) (Entered: 06/09/2025) (0) |
| Jun 9, 2025 | 396 | ORDER Dismissing without prejudice, Eugia's 339 Motion to Stay. Signed by Magistrate Judge Ann Marie Donio on 6/9/2025. (dmr) (Entered: 06/09/2025) (2) |
| Jun 9, 2025 | 397 | ORDER TO UNSEAL docket entries: D.I. 340 , D.I. 352 , D.I. 352-1. Signed by Magistrate Judge Ann Marie Donio on 6/9/2025. (dmr) (Entered: 06/09/2025) (2) |
| Jun 9, 2025 | 398 | OPINION. Signed by Judge Karen M. Williams on 6/9/2025. (sms2) (Entered: 06/10/2025) (10) |
| Jun 9, 2025 | 399 | ORDER Granting the 293 , 347 , 359 and 381 Motions to Seal. Signed by Judge Karen M. Williams on 6/9/2025. (sms2) (Entered: 06/10/2025) (2) |
| Jun 6, 2025 | 393 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Adjournment of June 11 Status Conference re 370 Order, 391 Order Setting Hearing on Motion. (CALMANN, ARNOLD) (Entered: 06/06/2025) (2) |
| Jun 6, 2025 | 394 | CONSOLIDATION ORDER: The 926 Action and the 3790 Action are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court; all filings in the Consolidated Actions shall use the 926 Action caption; all filings going forward shall be filed in the 926 Action and that the 3790 Action shall be administratively terminated by the Clerk's office; the Consolidated Actions will follow the schedule of the 926 Action as provided in the forthcoming amended scheduling order submitted by the parties in the lead case No. 1:23-00926-KMW-AMD reflecting the parties' agreement. Signed by Judge Karen M. Williams on 6/6/2025. (sms2) (Entered: 06/09/2025) (4) |
| Jun 5, 2025 | 391 | TEXT ORDER: The parties shall be prepared to address the Motion for Partial Stay [D.I. 339] at the upcoming telephonic conference on 6/11/2025 at 11:30 A.M. SO ORDERED by Magistrate Judge Ann Marie Donio on 6/5/2025. (slc) (Entered: 06/05/2025) (0) |
| Jun 5, 2025 | 392 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Stipulated Consent Judgment and Injunction. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 06/05/2025) (0) |
| Jun 4, 2025 | 390 | Letter from R Touhey Myer to the Honorable Ann Marie Donio, U.S.M.J. re Request to Unseal Briefing re 352 Brief in Opposition to Motion,,, 340 Exhibit (to Document),,. (MYER, R) (Entered: 06/04/2025) (2) |
| Jun 2, 2025 | 388 | AMENDED SCHEDULING ORDER: Defendants' deadline to file an answer in the 3790 Action is 6/2/2025. Amended Pleadings due by 9/30/2025. Pretrial Factual Discovery due by 10/30/2025. Signed by Magistrate Judge Ann Marie Donio on 6/2/2025. (dmr) (Entered: 06/02/2025) (5) |
| Jun 2, 2025 | 389 | LETTER ORDER Granting the parties' request to extend Eugia's deadline to file Eugia's Answer to the Complaint filed in C.A. No. I :25-cv- 03790-KMW-AMD until 6/13/2025 and to extend the deadline until 7/7/2025 by which Eugia must substantially complete its document production. Signed by Magistrate Judge Ann Marie Donio on 6/2/2025. (dmr) (Main Document 389 replaced on 6/4/2025) (tf, ). (Entered: 06/02/2025) (1) |
| May 30, 2025 | 385 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Consolidation Order. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 05/30/2025) (0) |
| May 30, 2025 | 386 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Enclosing Proposed Amended Scheduling Order re 385 Letter. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 05/30/2025) (0) |
| May 30, 2025 | 387 | Letter from R Touhey Myer to the Honorable Ann Marie Donio, U.S.M.J. Requesting Extension of Time to File Answer to Complaint (C.A. No. 1:25-cv-03790) and Substantial Completion of Document Production. (MYER, R) (Entered: 05/30/2025) (1) |
| May 27, 2025 | 378 | LETTER ORDER Granting Plaintiff's request for leave to file their Sur-Reply to Eugia's Reply Brief in Support of its Motion for Partial Stay of Discovery; Plaintiff's 377 Sur-Reply shall be considered filed as of May 21, 2025. Signed by Magistrate Judge Ann Marie Donio on 5/27/2025. (sms2) (Entered: 05/27/2025) (2) |
| May 27, 2025 | 379 | REDACTION to 332 Exhibit (to Document),,, --UNREDACTED Exhibit 2 to the Declaration of Ty Callahan, Esq. in Support of Plaintiffs' Motion to Exclude "Impossibility" Arguments and Opinions from Claim Construction Proceeding-- by MYLAN IRELAND LIMITED, THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., VIATRIS SPECIALTY LLC. (Attachments: # 1 REDACTED Exhibit 3 to the Declaration of Ty Callahan, Esq. in Support of Plaintiffs' Motion to Exclude, # 2 UNREDACTED Exhibit 5)(CALMANN, ARNOLD) (Entered: 05/27/2025) (0) |
| May 27, 2025 | 380 | REDACTION to 372 Reply Brief to Opposition to Motion,,, --UNREDACTED REPLY BRIEF-- by MYLAN IRELAND LIMITED, THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., VIATRIS SPECIALTY LLC. (Attachments: # 1 UNREDACTED Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 05/27/2025) (0) |
| May 27, 2025 | 381 | MOTION to Seal Document 354 Brief in Opposition to Motion,, 356 Exhibit (to Document),, 332 Exhibit (to Document),,, by CIPLA LIMITED, CIPLA USA, INC.. (Attachments: # 1 Declaration of Loly G. Tor, # 2 Appendix A (Index), # 3 Text of Proposed Order)(TOR, LOLY) (Entered: 05/27/2025) (0) |
| May 27, 2025 | 382 | REDACTION to 332 Exhibit (to Document),,, by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY) (Entered: 05/27/2025) (30) |
| May 27, 2025 | 383 | REDACTION to 354 Brief in Opposition to Motion,, by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY) (Entered: 05/27/2025) (18) |
| May 27, 2025 | 384 | REDACTION to 356 Exhibit (to Document),, by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY) (Entered: 05/27/2025) (30) |
| May 21, 2025 | 376 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. re 373 Reply Brief to Opposition to Motion. (CALMANN, ARNOLD) (Entered: 05/21/2025) (2) |
| May 21, 2025 | 377 | BRIEF in Opposition filed by MYLAN IRELAND LIMITED, THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., VIATRIS SPECIALTY LLC re 339 MOTION to Stay Discovery (Partial Stay) (CALMANN, ARNOLD) (Entered: 05/21/2025) (8) |
| May 19, 2025 | 375 | CONSENT ORDER REGARDING SUBSTITUTION OF PARTY: Plaintiff Mylan Specialty L.P. shall be referred to in this matter by its new name, Viatris Specialty LLC; the caption in this matter shall be amended to replace Mylan Specialty L.P. with Viatris Specialty LLC. Signed by Magistrate Judge Ann Marie Donio on 5/19/2025. (kes, ) (Entered: 05/19/2025) (2) |
| May 16, 2025 | 374 | REDACTION to 349 Brief in Opposition to Motion,,, --UNREDACTED Plaintiffs' Sur-Reply Brief-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (CALMANN, ARNOLD) (Entered: 05/16/2025) (12) |
| May 12, 2025 | 371 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Enclosing Proposed Consent Order Regarding Substitution of Party. (CALMANN, ARNOLD) (Entered: 05/12/2025) (4) |
| May 12, 2025 | 372 | REPLY BRIEF to Opposition to Motion filed by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. re 331 MOTION To Exclude Defendants' "Impossibility" Arguments and Opinions from Claim Construction Proceeding (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 05/12/2025) (0) |
| May 12, 2025 | 373 | REPLY BRIEF to Opposition to Motion filed by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC re 339 MOTION to Stay Discovery (Partial Stay) (MYER, R) (Entered: 05/12/2025) (12) |
| May 8, 2025 | 370 | TEXT ORDER: The Court will conduct a telephonic conference on 6/11/2025 at 11:30 A.M. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 749 623 882#. SO ORDERED by Magistrate Judge Ann Marie Donio on 5/8/2025. (slc) (Entered: 05/08/2025) (0) |
| May 7, 2025 | 368 | LETTER ORDER Granting Plaintiffs' request for leave to file their Sur-Reply to Eugia's Reply Brief in Support of its Partial l Motion to Dismiss for Lack of Subject Matter Jurisdiction; ORDERED that Plaintiffs' Sur-Reply (ECF No. 349 ) shall be considered filed as of April 28, 2025. Signed by Judge Karen M. Williams on 5/7/2025. (dmr) (Entered: 05/07/2025) (2) |
| May 7, 2025 | 369 | REDACTION to 310 Markman Opening Brief,,, --UNREDACTED Exhibit 11 to the Declaration of Nicholas Bortz in Support of Plaintiffs' Opening Claim Construction Brief-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (CALMANN, ARNOLD) (Entered: 05/07/2025) (8) |
| May 6, 2025 | 358 | Letter from Arnold B. Calmann, Esq., on behalf of Plaintiffs and Defendants Cipla and Mankind, to the Honorable Karen M. Williams, U.S.D.J. Regarding Markman Hearing. (CALMANN, ARNOLD) (Entered: 05/06/2025) (2) |
| May 6, 2025 | 359 | Joint MOTION to Seal Document 310 Markman Opening Brief,,, 333 Markman Response Brief,, 338 Exhibit (to Document),, 335 Brief,, Cipla Limited and Cipla USA, Inc. and Mankind Pharma Ltd. and Lifestar Pharma LLC by CIPLA LIMITED, CIPLA USA, INC.. (Attachments: # 1 Declaration of Loly G. Tor, # 2 Declaration of Jay P. Lessler, # 3 Appendix A to Motion to Seal, # 4 Text of Proposed Order)(TOR, LOLY) (Entered: 05/06/2025) (0) |
| May 6, 2025 | 360 | REDACTION to 310 Markman Opening Brief,,, by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY) (Entered: 05/06/2025) (30) |
| May 6, 2025 | 361 | REDACTION to 310 Markman Opening Brief,,, Redactions to ECF 310-1, Declaration of Allan S. Myerson, PhD by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY) (Entered: 05/06/2025) (30) |
| May 6, 2025 | 362 | REDACTION to 333 Markman Response Brief,, by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY) (Entered: 05/06/2025) (30) |
| May 6, 2025 | 363 | REDACTION to 333 Markman Response Brief,, Redactions to ECF 333-2, Rebuttal Declaration of Allan S. Myerson, PhD by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY) (Entered: 05/06/2025) (30) |
| May 6, 2025 | 364 | REDACTION to 335 Brief,, by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY) (Entered: 05/06/2025) (30) |
| May 6, 2025 | 365 | REDACTION to 338 Exhibit (to Document),, by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY) (Entered: 05/06/2025) (30) |
| May 6, 2025 | 366 | REDACTION to 310 Markman Opening Brief,,, --REDACTED IN ENTIRETY Exhibit 2 to the Declaration of Nicholas D. Bortz in Support of Plaintiffs' Opening Claim Construction Brief-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 REDACTED IN ENTIRETY Exhibit 10, # 2 REDACTED IN ENTIRETY Exhibit 12)(CALMANN, ARNOLD) (Entered: 05/06/2025) (0) |
| May 6, 2025 | 367 | REDACTION to 333 Markman Response Brief,, --REDACTED IN ENTIRETY Exhibit 20 to the Declaration of Nicholas D. Bortz, Esq. in Support of Plaintiffs' Responsive Claim Construction Brief-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (CALMANN, ARNOLD) (Entered: 05/06/2025) (1) |
| May 5, 2025 | 352 | BRIEF in Opposition filed by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. re 339 MOTION to Stay Discovery (Partial Stay) (Attachments: # 1 Exhibit A to the Declaration of Daniel Sokoloff, Esq. in Support of Plaintiffs' Brief in Opposition to Eugia's Motion for Partial Stay of Discovery)(CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 05/05/2025) (0) |
| May 5, 2025 | 353 | DECLARATION of Daniel Sokoloff, Esq. in Support of Plaintiffs' Brief in Opposition to Eugia's Partial Motion to Stay Discovery re 352 Brief in Opposition to Motion,,, by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Certificate of Service)(CALMANN, ARNOLD) (Entered: 05/05/2025) (0) |
| May 5, 2025 | 354 | BRIEF in Opposition filed by CIPLA LIMITED, CIPLA USA, INC. re 331 MOTION To Exclude Defendants' "Impossibility" Arguments and Opinions from Claim Construction Proceeding (TOR, LOLY)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 05/05/2025) (0) |
| May 5, 2025 | 355 | DECLARATION of Loly G. Tor re 354 Brief in Opposition to Motion,, by CIPLA LIMITED, CIPLA USA, INC.. (Attachments: # 1 Exhibit 2)(TOR, LOLY) (Entered: 05/05/2025) (0) |
| May 5, 2025 | 356 | Exhibit to 355 Declaration Exhibit 1 to Declaration of Loly G. Tor by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 05/05/2025) (0) |
| May 5, 2025 | 357 | Exhibit to 355 Declaration Exhibit 3 to Declaration of Loly G. Tor by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 05/05/2025) (0) |
| May 2, 2025 | 351 | Letter from Loly G. Tor to Hon. Ann Marie Donio, U.S.M.J. re: Request to Extend Deadline to File Motion to Seal. (TOR, LOLY) (Entered: 05/02/2025) (1) |
| Apr 30, 2025 | 350 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. re 343 Order, 324 Order,,. (CALMANN, ARNOLD) (Entered: 04/30/2025) (1) |
| Apr 28, 2025 | 343 | LETTER ORDER Granting Plaintiffs' request for an extension until 4/29/2025 to file a letter pursuant to Local Civil Rule 37.1 regarding unresolved issues concerning Eugia's objections to Plaintiffs' revised discovery requests. Signed by Magistrate Judge Ann Marie Donio on 4/28/2025. (dmr) (Entered: 04/28/2025) (2) |
| Apr 28, 2025 | 344 | REDACTION to 322 Brief in Opposition to Motion,,, --UNREDACTED Opposition Brief-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 REDACTED Exhibit A to the Declaration of Matthew V. Anderson, Esq. in Support of Plaintiffs' Opposition to Eugia's Partial Motion to Dismiss, # 2 REDACTED Exhibit B, # 3 UNREDACTED Exhibit C, # 4 UNREDACTED Exhibit D, # 5 REDACTED Exhibit E)(CALMANN, ARNOLD) (Entered: 04/28/2025) (0) |
| Apr 28, 2025 | 345 | REDACTION to 304 Exhibit (to Document),, Brief in Support of Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (MYER, R) (Entered: 04/28/2025) (20) |
| Apr 28, 2025 | 346 | REDACTION to 306 Exhibit (to Document),,, Declaration, Exhibit 1 to Declaration of Timothy H. Kratz in Support of Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14)(MYER, R) (Entered: 04/28/2025) (0) |
| Apr 28, 2025 | 347 | MOTION to Seal (Unopposed) by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (Attachments: # 1 Declaration of George J. Barry, III in Support of Unopposed Motion to Seal, # 2 Exhibit 1- Defendants' Index of Redactions, # 3 Text of Proposed Order, # 4 Certificate of Service)(MYER, R) (Entered: 04/28/2025) (0) |
| Apr 28, 2025 | 348 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. re 327 Reply Brief to Opposition to Motion,. (CALMANN, ARNOLD) (Entered: 04/28/2025) (2) |
| Apr 28, 2025 | 349 | BRIEF in Opposition filed by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. re 303 MOTION to Dismiss for Lack of Jurisdiction (Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction) --Plaintiffs' [Proposed] Sur-Reply Brief in Response to Eugia's Reply Brief (Dkt. No. 327) in Support of its Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction-- (CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 04/28/2025) (0) |
| Apr 25, 2025 | 341 | Letter from Arnold B. Calmann, Esq., on behalf of Plaintiffs and Defendants Cipla and Mankind, to the Honorable Karen M. Williams, U.S.D.J. Pursuant to L. Pat. R. 4.6 Regarding Markman Hearing. (CALMANN, ARNOLD) (Entered: 04/25/2025) (2) |
| Apr 25, 2025 | 342 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Extension of Time to File Letter Pursuant to Local Civil Rule 37.1 Regarding Eugia Discovery re 324 Order,,. (CALMANN, ARNOLD) (Entered: 04/25/2025) (2) |
| Apr 22, 2025 | 339 | MOTION to Stay Discovery (Partial Stay) by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (Attachments: # 1 Text of Proposed Order, # 2 Certificate of Service)(MYER, R) (Entered: 04/22/2025) (0) |
| Apr 22, 2025 | 340 | Exhibit to 339 Motion to Stay Discovery (Partial Stay), Brief in Support of Motion for Partial Stay of Discovery by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (MYER, R)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 04/22/2025) (20) |
| Apr 18, 2025 | 331 | MOTION To Exclude Defendants' "Impossibility" Arguments and Opinions from Claim Construction Proceeding by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Brief, # 2 Declaration of Ty W. Callahan, Esq., # 3 Exhibit 1 to the Declaration of Ty W. Callahan, Esq., # 4 Exhibit 4, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 04/18/2025) (0) |
| Apr 18, 2025 | 332 | Exhibit to 331 Motion for Miscellaneous Relief,, --Exhibit 2 to the Declaration of Ty W. Callahan, Esq. in Support of Plaintiffs' Motion To Exclude Defendants' "Impossibility" Arguments and Opinions from Claim Construction Proceeding by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 5)(CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 04/18/2025) (0) |
| Apr 18, 2025 | 333 | MARKMAN RESPONSE BRIEF re 312 Markman Opening Brief,,,,, (Attachments: # 1 Exhibit 20 to the Declaration of Nicholas D. Bortz, Esq. in Support of Plaintiffs' Responsive Claim Construction Brief, # 2 Rebuttal Declaration of Allan S. Myerson, Ph.D.)(CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 04/18/2025) (0) |
| Apr 18, 2025 | 334 | DECLARATION of Nicholas D. Bortz, Esq. in Support of Plaintiffs' Responsive Claim Construction Brief re 333 Markman Response Brief,, by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Exhibit 19 to the Declaration of Nicholas D. Bortz, Esq., # 2 Exhibit 21)(CALMANN, ARNOLD) (Entered: 04/18/2025) (0) |
| Apr 18, 2025 | 335 | BRIEF (Cipla Limited and Cipla USA Inc. Rebuttal Claim Construction Brief) (TOR, LOLY)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 04/18/2025) (0) |
| Apr 18, 2025 | 336 | DECLARATION of Loly G. Tor re 335 Brief,, by CIPLA LIMITED, CIPLA USA, INC.. (Attachments: # 1 Exhibit A to Loly G. Tor Declaration ISO Defendants' Rebuttal Claim Construction Brief, # 2 Exhibit B to Loly G. Tor Declaration ISO Defendants' Rebuttal Claim Construction Brief, # 3 Exhibit C to Loly G. Tor Declaration ISO Defendants' Rebuttal Claim Construction Brief (Filed Under Seal))(TOR, LOLY) (Entered: 04/18/2025) (0) |
| Apr 18, 2025 | 337 | DECLARATION of Dr. Michael Zaworotko re 335 Brief,, (Defendants' Rebuttal Claim Construction Brief) by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY) (Entered: 04/18/2025) (30) |
| Apr 18, 2025 | 338 | Exhibit to 336 Declaration, (Exhibit C to Loly G. Tor Declaration ISO Defendants' Rebuttal Claim Construction Brief) by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 04/18/2025) (0) |
| Apr 17, 2025 | 330 | Transcript of Telephonic Discovery Conference held on 04/11/2025, before Judge Anne Marie Donio. Court Reporter/Transcriber Diana Doman Transcribing, LLC ((856) 435-7172). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter/Transcription Agency due, but not filed, by 5/8/2025. Redacted Transcript Deadline set for 5/19/2025. Release of Transcript Restriction set for 7/16/2025. (aji, ) (Entered: 04/17/2025) (0) |
| Apr 15, 2025 | 328 | ORDER granting 326 Motion for Leave to Appear Pro Hac Vice as to Ty W. Callahan, Esquire. Signed by Magistrate Judge Ann Marie Donio on 04/15/2025. (aji, ) (Entered: 04/15/2025) (3) |
| Apr 15, 2025 | 329 | Notice of Request by Pro Hac Vice Ty W. Callahan, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 250 receipt number ANJDC-16176683.) (CALMANN, ARNOLD) (Entered: 04/15/2025) (2) |
| Apr 14, 2025 | 326 | MOTION for Leave to Appear Pro Hac Vice by Ty W. Callahan, Esq. (Unopposed) by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P.. (Attachments: # 1 Certification of Arnold B. Calmann, Esq., # 2 Declaration of Ty W. Callahan, Esq., # 3 Text of Proposed Order, # 4 Certificate of Service)(CALMANN, ARNOLD) (Entered: 04/14/2025) (0) |
| Apr 14, 2025 | 327 | REPLY BRIEF to Opposition to Motion filed by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC re 303 MOTION to Dismiss for Lack of Jurisdiction (Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction) (MYER, R) (Entered: 04/14/2025) (20) |
| Apr 11, 2025 | 324 | ORDER directing Plaintiffs to serve on the Eugia Defendants revised discovery requests and proposed ESI search terms by April 16, 2025; no later than April 21, 2025, the Eugia Defendants shall serve any objections to such requests; Plaintiffs and the Eugia Defendants shall meet and confer with regard to any issues concerning such objections; any issue that cannot be resolved by way of agreement shall be brought before the Court by way of letter by no later than April 25, 2025; directing the Eugia Defendants to file a formal motion for a partial stay of discovery by April 22, 2025. Signed by Magistrate Judge Ann Marie Donio on 4/11/2025. (sms2) (Entered: 04/11/2025) (2) |
| Apr 11, 2025 | 325 | Minute Entry for proceedings held before Magistrate Judge Ann Marie Donio: Telephonic Discovery Conference held on 4/11/2025. Order to be entered. (Court Reporter, Court Conference Line) (sb) (Entered: 04/14/2025) (1) |
| Apr 7, 2025 | 322 | BRIEF in Opposition filed by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. re 303 MOTION to Dismiss for Lack of Jurisdiction (Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction) (Attachments: # 1 Exhibit A to the Declaration of Matthew V. Anderson, Esq. in Support of Plaintiffs' Opposition to Eugia's Partial Motion to Dismiss, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 04/07/2025) (0) |
| Apr 7, 2025 | 323 | DECLARATION of Matthew V. Anderson, Esq. in Support of Plaintiffs' Opposition to Eugia's Partial Motion to Dismiss re 322 Brief in Opposition to Motion,,, by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Certificate of Service)(CALMANN, ARNOLD) (Entered: 04/07/2025) (0) |
| Mar 28, 2025 | 321 | TEXT ORDER: Due to a change in the Court's calendar, the telephonic status/discovery conference on 4/4/2025 shall be, and is hereby, RESCHEDULED to 4/11/2025 at 1:30 P.M. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 848 710 605#. SO ORDERED by Magistrate Judge Ann Marie Donio on 3/28/2025. (slc) (Entered: 03/28/2025) (0) |
| Mar 21, 2025 | 320 | LETTER ORDER Granting Plaintiffs' request to unseal ECF Nos. 307 , 307 -1 309 , 309 -1 & 314 . Signed by Magistrate Judge Ann Marie Donio on 3/21/2025. (sms2) (Entered: 03/21/2025) (1) |
| Mar 20, 2025 | 317 | TEXT ORDER: Plaintiff's letter request [D.I. 316] to adjourn the the telephonic status conference scheduled for March 25, 2025 shall be, and is hereby, GRANTED. A new date will be set. SO ORDERED by Magistrate Judge Ann Marie Donio on 3/20/2025. (sb) (Entered: 03/20/2025) (0) |
| Mar 20, 2025 | 318 | TEXT ORDER: The telephonic status/discovery conference on 3/25/2025 shall be, and is hereby, RESCHEDULED to 4/4/2025 at 11:00 A.M. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 848 710 605#. SO ORDERED by Magistrate Judge Ann Marie Donio on 3/20/2025. (slc) (Entered: 03/20/2025) (0) |
| Mar 20, 2025 | 319 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Regarding Unsealing re 314 Letter,, 307 Letter,, 309 Letter,,. (CALMANN, ARNOLD) (Entered: 03/20/2025) (1) |
| Mar 19, 2025 | 316 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Rescheduling of March 25, 2025 Telephonic Status/Discovery Conference (Unopposed) re 315 Order,. (CALMANN, ARNOLD) (Entered: 03/19/2025) (2) |
| Mar 11, 2025 | 315 | TEXT ORDER: The Court will conduct a telephonic status/discovery conference on 3/25/2025 at 11:45 A.M. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 848 710 605#. SO ORDERED by Magistrate Judge Ann Marie Donio on 3/11/2025. (slc) (Entered: 03/11/2025) (0) |
| Mar 7, 2025 | 314 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. re 309 Letter,,. (CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 03/07/2025) (3) |
| Mar 6, 2025 | 313 | Rule 7.1(d)(5) Letter for an automatic extension of the return date of a dispositive motion re 303 MOTION to Dismiss for Lack of Jurisdiction (Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction) . (CALMANN, ARNOLD) (Entered: 03/06/2025) (1) |
| Feb 28, 2025 | 309 | Letter from R Touhey Myer to the Honorable Ann Marie Donio, U.S.M.J. re 307 Letter,,. (Attachments: # 1 Exhibit A)(MYER, R)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 02/28/2025) (0) |
| Feb 28, 2025 | 310 | MARKMAN OPENING BRIEF of Plaintiffs (Attachments: # 1 Declaration of Allan S. Myerson, Ph.D. in Support of Plaintiffs' Opening Claim Construction Brief, # 2 Exhibit 2 to the Declaration of Nicholas D. Bortz in Support of Plaintiffs' Opening Claim Construction Brief, # 3 Exhibit 10 to the Bortz Declaration, # 4 Exhibit 11, # 5 Exhibit 12)(CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 02/28/2025) (0) |
| Feb 28, 2025 | 311 | DECLARATION of Nicholas D. Bortz, Esq. in Support of Plaintiffs' Opening Claim Construction Brief re 310 Markman Opening Brief,,, by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Exhibit 1 to the Declaration of Nicholas D. Bortz, Esq., # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 13, # 10 Exhibit 14, # 11 Exhibit 15, # 12 Exhibit 16, # 13 Exhibit 17, # 14 Exhibit 18)(CALMANN, ARNOLD) (Entered: 02/28/2025) (0) |
| Feb 28, 2025 | 312 | MARKMAN OPENING BRIEF on behalf of Defendants (Attachments: # 1 Declaration of Dr. Michael Zaworotko, # 2 Declaration of Loly G. Tor, # 3 Exhibit A to Tor Decl., # 4 Exhibit B to Tor Decl., # 5 Exhibit C to Tor Decl., # 6 Exhibit D to Tor Decl., # 7 Exhibit E to Tor Decl., # 8 Exhibit F to Tor Decl., # 9 Exhibit G to Tor Decl., # 10 Exhibit H to Tor Decl., # 11 Exhibit I to Tor Decl., # 12 Exhibit J to Tor Decl., # 13 Exhibit K to Tor Decl., # 14 Exhibit L to Tor Decl., # 15 Exhibit M to Tor Decl., # 16 Exhibit N to Tor Decl., # 17 Exhibit O to Tor Decl., # 18 Exhibit P to Tor Decl., # 19 Exhibit Q to Tor Decl., # 20 Exhibit R to Tor Decl., # 21 Exhibit S to Tor Decl., # 22 Exhibit T to Tor Decl., # 23 Exhibit U to Tor Decl., # 24 Exhibit V to Tor Decl., # 25 Exhibit W to Tor Decl., # 26 Exhibit X to Tor Decl., # 27 Exhibit Y to Tor Decl., # 28 Exhibit Z to Tor Decl., # 29 Exhibit AA to Tor Decl., # 30 Exhibit AB to Tor Decl., # 31 Exhibit AC to Tor Decl., # 32 Exhibit AD to Tor Decl., # 33 Exhibit AE to Tor Decl., # 34 Exhibit AF to Tor Decl., # 35 Exhibit AG to Tor Decl., # 36 Exhibit AH to Tor Decl., # 37 Exhibit AI to Tor Decl., # 38 Exhibit AJ to Tor Decl.)(TOR, LOLY) (Entered: 02/28/2025) (0) |
| Feb 25, 2025 | 307 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Regarding Application to Compel Production of Documents from Eugia. (Attachments: # 1 Exhibit 5)(CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 02/25/2025) (0) |
| Feb 25, 2025 | 308 | Exhibit to 307 Letter,, --Exhibit 1-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 02/25/2025) (0) |
| Feb 24, 2025 | 303 | MOTION to Dismiss for Lack of Jurisdiction (Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction) by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. Responses due by 3/24/2025. (Attachments: # 1 Text of Proposed Order, # 2 Certificate of Service)(MYER, R) (Entered: 02/24/2025) (0) |
| Feb 24, 2025 | 304 | Exhibit to 303 Motion to Dismiss/Lack of Jurisdiction, Brief in Support of Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (MYER, R)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 02/24/2025) (0) |
| Feb 24, 2025 | 305 | DECLARATION of Timothy H. Kratz re 303 MOTION to Dismiss for Lack of Jurisdiction (Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction) by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (MYER, R) (Entered: 02/24/2025) (5) |
| Feb 24, 2025 | 306 | Exhibit to 305 Declaration, Exhibit 1 to Declaration of Timothy H. Kratz in Support of Partial Motion to Dismiss for Lack of Subject Matter Jurisdiction by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14)(MYER, R)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 02/24/2025) (0) |
| Feb 11, 2025 | 302 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Joint Claim Construction and Prehearing Statement and Exhibit A thereto. (Attachments: # 1 Joint Claim Construction and Prehearing Statement, # 2 Exhibit A to Joint Claim Construction and Prehearing Statement)(CALMANN, ARNOLD) (Entered: 02/11/2025) (0) |
| Feb 10, 2025 | 300 | LETTER ORDER Granting extension of the current case schedule; Parties shall file a joint Claim Construction and prehearing statement by 2/11/2025. Signed by Magistrate Judge Ann Marie Donio on 2/10/2025. (sms2) (Entered: 02/10/2025) (2) |
| Feb 10, 2025 | 301 | NOTICE by THERAVANCE BIOPHARMA US, INC. of Name Change (CALMANN, ARNOLD) (Entered: 02/10/2025) (2) |
| Feb 7, 2025 | 299 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Extension of Time to File Joint Claim Construction and Prehearing Statement re 298 Order. (CALMANN, ARNOLD) (Entered: 02/07/2025) (2) |
| Feb 4, 2025 | 298 | LETTER ORDER Granting the Defendants' 297 consented request for an extension of the current case schedule, as it relates to certain claim construction deadlines. Signed by Magistrate Judge Ann Marie Donio on 2/4/2025. (mag) (Entered: 02/04/2025) (2) |
| Jan 31, 2025 | 297 | Letter from Defendants requesting consented-to extension of current schedule re 295 Scheduling Order. (TOR, LOLY) (Entered: 01/31/2025) (2) |
| Nov 7, 2024 | 296 | ANSWER to Counterclaim by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 11/07/2024) (13) |
| Nov 1, 2024 | 294 | Letter from Loly G. Tor to Hon. Ann Marie Donio, U.S.M.J. re: Proposed Amended Scheduling Order. (Attachments: # 1 Text of Proposed Order Proposed Amended Scheduling Order)(TOR, LOLY) (Entered: 11/01/2024) (0) |
| Nov 1, 2024 | 295 | AMENDED SCHEDULING ORDER: Amended Pleadings due by 8/26/2025. Pretrial Factual Discovery due by 10/9/2025. Signed by Magistrate Judge Ann Marie Donio on 11/1/2024. (dmr) (Entered: 11/01/2024) (5) |
| Oct 29, 2024 | 291 | REDACTION to 261 Exhibit (to Document),,,, --REDACTED Exhibit 2-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 REDACTED Exhibit 3, # 2 REDACTED Exhibit 10, # 3 REDACTED Exhibit 11)(CALMANN, ARNOLD) (Entered: 10/29/2024) (0) |
| Oct 29, 2024 | 292 | REDACTION to 270 Letter,, by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 REDACTED Exhibit Z)(CALMANN, ARNOLD) (Entered: 10/29/2024) (0) |
| Oct 29, 2024 | 293 | MOTION to Seal Document 261 Exhibit (to Document),,,, 270 Letter,, Exhibits 2, 3, 10, and 11 to Eugia's Motion for Summary Judgment and Eugia's September 13, 2024 Letter and Exhibit Z thereto by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Declaration of Matthew V. Anderson, Esq. in Support of Unopposed Motion to Seal, # 2 Declaration of Mary W. Bourke, Esq., in Support of Unopposed Motion to Seal, # 3 Appendix A -- Index in Support of Unopposed Motion to Seal, # 4 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 10/29/2024) (0) |
| Oct 17, 2024 | 288 | ANSWER to Complaint in Consolidated Action 1:24-cv-08558 (KMW)(AMD) by LIFESTAR PHARMA LLC, MANKIND PHARMA LTD..(DARBEE, MICHAEL) (Entered: 10/17/2024) (29) |
| Oct 17, 2024 | 289 | ANSWER to Complaint , Separate Defenses and, COUNTERCLAIM against All Plaintiffs by CIPLA USA, INC., CIPLA LIMITED.(TOR, LOLY) (Entered: 10/17/2024) (30) |
| Oct 17, 2024 | 290 | Corporate Disclosure Statement by CIPLA LIMITED, CIPLA USA, INC. identifying InvaGen Pharmaceuticals, Inc., Cipla (EU Limited) and Cipla Limited as Corporate Parent.. (TOR, LOLY) (Entered: 10/17/2024) (3) |
| Oct 16, 2024 | 287 | LETTER ORDER Granting Plaintiffs' 285 joint request for an extension of the deadline to file the motions to seal and redactions; the Parties shall file an omnibus motion to seal and their redactions on 10/29/2024. Signed by Judge Karen M. Williams on 10/16/2024. (mag) (Entered: 10/16/2024) (2) |
| Oct 15, 2024 | 284 | AMENDED SCHEDULING ORDER: Amended Pleadings or motion to join new parties due by 8/26/2025. Pretrial Fact Discovery due by 10/9/2025. Signed by Magistrate Judge Ann Marie Donio on 10/15/2024. (db, ) Modified on 10/16/2024 (tf, ). (Entered: 10/15/2024) (6) |
| Oct 15, 2024 | 285 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Leave and Extension of Time to File Omnibus Motion to Seal and Redactions re 259 Exhibit (to Document),, 261 Exhibit (to Document),,,, 271 Letter,, 281 Transcript,,, 270 Letter,, 265 Letter,, 260 Exhibit (to Document),, 276 Letter,,, 262 Exhibit (to Document),,. (CALMANN, ARNOLD) (Entered: 10/15/2024) (2) |
| Oct 15, 2024 | 286 | CONSOLIDATION ORDER: The 926 Action and the 8558 Action are consolidated for all purposes, including discovery, case management, and trial, subject to further Order of the Court; all filings in the Consolidated Actions shall use the 926 Action Caption; all filings going forward shall be made in the 926 Action; and the 8558 Action shall be administratively terminated by the Clerk's Office; the Consolidated Actions will follow the amended schedule of the 926 Action. Signed by Judge Karen M. Williams on 10/15/2024. (sms2) (Entered: 10/16/2024) (4) |
| Oct 14, 2024 | 283 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Enclosing Proposed Amended Scheduling Order. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 10/14/2024) (0) |
| Oct 11, 2024 | 282 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Consolidation Order (Consolidation with 24-8558-KMW-AMD). (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 10/11/2024) (0) |
| Oct 8, 2024 | 281 | Transcript of Telephone Conference held on 10/3/2024, before Judge Karen M. Williams. Court Reporter: Sharon Ricci (267-249-8780). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter Agency due, but not filed, by 10/29/2024. Redacted Transcript Deadline set for 11/8/2024. Release of Transcript Restriction set for 1/6/2025. (sms2) (Entered: 10/08/2024) (0) |
| Oct 3, 2024 | 279 | TEXT ORDER For the reasons set forth on the record during the October 3, 2024 On the Record Telephone Motion Conference re 258 Motion for Summary Judgment of Non-Infringement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, it is hereby ORDERED that the Motion for Summary Judgment is TERMINATED as premature, without prejudice to refile upon the completion of discovery. So Ordered by Judge Karen M. Williams on 10/3/24. (nar) (Entered: 10/03/2024) (0) |
| Oct 3, 2024 | 280 | Minute Entry for proceedings held before Judge Karen M. Williams: Motion Conference held by telephone on 10/3/2024. Telephone Conference held on the record re 258 MOTION for Summary Judgment of Non-Infringement by EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LIMITED. Ordered 258 Motion TERMINATED, as premature. Order entered. (Court Reporter, Sharon Ricci (267-249-8780)) (mag) (Entered: 10/04/2024) (1) |
| Oct 1, 2024 | 277 | Letter from R Touhey Myer to the Honorable Karen M. Williams and the Honorable Ann Marie Donio re 276 Letter,,,. (MYER, R) (Entered: 10/01/2024) (1) |
| Oct 1, 2024 | 278 | TEXT ORDER The Court has scheduled an On the Record Telephone Scheduling Conference for 10/3/2024 at 10:00 AM to address counsel's letters related to the pending Motion for Summary Judgment. The Court will email counsel the dial-in information prior to the conference. So Ordered by Judge Karen M. Williams on 10/1/24. (nar) (Entered: 10/01/2024) (0) |
| Sep 30, 2024 | 276 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. and the Honorable Ann Marie Donio, U.S.M.J. Regarding Plaintiffs' Request for An Extension of Time On Emergent Basis to File Opposition to Eugia's Motion for Summary Judgment re 258 MOTION for Summary Judgment of Non-Infringement, 271 Letter,, 274 Letter, 270 Letter,, 265 Letter,, 275 Letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/30/2024) (0) |
| Sep 27, 2024 | 275 | Letter from R Touhey Myer to the Honorable Karen M. Williams and the Honorable Ann Marie Donio re 274 Letter,. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(MYER, R) (Entered: 09/27/2024) (0) |
| Sep 26, 2024 | 274 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. and the Honorable Ann Marie Donio, U.S.M.J. re 271 Letter,, 266 Exhibit (to Document), 270 Letter,, 265 Letter,,. (Attachments: # 1 Exhibit A)(CALMANN, ARNOLD) (Entered: 09/26/2024) (0) |
| Sep 20, 2024 | 273 | Transcript of Status Conference held on 6/24/2024, before Judge Ann Marie Donio. Court Reporter/Transcriber Diana Doman Transcribing, LLC ((856) 435-7172). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter/Transcription Agency due, but not filed, by 10/11/2024. Redacted Transcript Deadline set for 10/21/2024. Release of Transcript Restriction set for 12/19/2024. (dmr) (Entered: 09/20/2024) (9) |
| Sep 19, 2024 | 272 | Rule 7.1(d)(5) Letter for an automatic extension of the return date of a dispositive motion re 258 MOTION for Summary Judgment of Non-Infringement . (CALMANN, ARNOLD) (Entered: 09/19/2024) (1) |
| Sep 16, 2024 | 271 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. and the Honorable Ann Marie Donio, U.S.M.J. Regarding Eugia's Motion for Summary Judgment re 270 Letter,,. (CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/16/2024) (0) |
| Sep 13, 2024 | 269 | Transcript of Telephonic Discovery and Status Conference held on 9/11/2024, before Judge Donio. Court Reporter/Transcriber Diana Doman Transcribing, LLC (856-435-7172). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter/Transcription Agency due, but not filed, by 10/4/2024. Redacted Transcript Deadline set for 10/15/2024. Release of Transcript Restriction set for 12/12/2024. (js) (Entered: 09/13/2024) (25) |
| Sep 13, 2024 | 270 | Letter from R Touhey Myer re Eugua Defendants' Motion for Summary Judgment re 268 Order,. (Attachments: # 1 Exhibit Y, # 2 Exhibit Z)(MYER, R)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/13/2024) (0) |
| Sep 11, 2024 | 267 | Minute Entry for proceedings held before Magistrate Judge Ann Marie Donio: Telephonic Discovery and Status Conference held on 9/11/2024. Order to be entered. (Court Reporter, Court Conference Line) (sb) (Entered: 09/11/2024) (1) |
| Sep 11, 2024 | 268 | TEXT ORDER: As set forth on the record on September 11, 2024, Eugia shall file by no later than September 13, 2024 a letter to the District Judge in response to Plaintiffs' letter [D.I. 265] regarding Eugia's motion for summary judgment. SO ORDERED by Magistrate Judge Ann Marie Donio on 9/11/2024. (slc) (Entered: 09/11/2024) (0) |
| Sep 10, 2024 | 265 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. and the Honorable Ann Marie Donio, U.S.M.J. Regarding Eugia's Motion for Summary Judgment re 258 MOTION for Summary Judgment of Non-Infringement. (CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/10/2024) (0) |
| Sep 10, 2024 | 266 | Exhibit to 265 Letter,, --Exhibit A-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (CALMANN, ARNOLD) (Entered: 09/10/2024) (7) |
| Sep 5, 2024 | 263 | Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney JAMES S. RICHTER terminated. (RICHTER, JAMES) (Entered: 09/05/2024) (2) |
| Sep 5, 2024 | 264 | DECLARATION of Timothy H. Kratz re 258 MOTION for Summary Judgment of Non-Infringement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (MYER, R) (Entered: 09/05/2024) (6) |
| Sep 4, 2024 | 258 | MOTION for Summary Judgment of Non-Infringement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. Responses due by 9/23/2024. (Attachments: # 1 Declaration of Timothy H. Kratz in Support of Motion for Summary Judgment of Non-Infringement, # 2 Text of Proposed Order, # 3 Certificate of Service)(MYER, R) (Entered: 09/04/2024) (0) |
| Sep 4, 2024 | 259 | Exhibit to 258 Motion for Summary Judgment, Brief in Support of Motion for Summary Judgment of Non-Infringement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (MYER, R)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/04/2024) (0) |
| Sep 4, 2024 | 260 | Exhibit to 258 Motion for Summary Judgment, Statement of Material Facts Not In Dispute by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (MYER, R)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/04/2024) (0) |
| Sep 4, 2024 | 261 | Exhibit to 258 Motion for Summary Judgment, Exhibit 1 to Declaration of Timothy H. Kratz in Support of Defendant's Motion for Summary Judgment of Non-Infringement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16, # 16 Exhibit 17)(MYER, R)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/04/2024) (0) |
| Sep 4, 2024 | 262 | Exhibit to 258 Motion for Summary Judgment, Declaration of Paul McMahon in Support of Defendants' Motion for Summary Judgment of Non-Infringement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (MYER, R)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/04/2024) (0) |
| Jul 1, 2024 | 256 | ORDER To Seal. ORDERED that the Exhibit E to the Warner Certification, filed on the docket at D.I. 218-3, shall remain under seal. Signed by Magistrate Judge Ann Marie Donio on 7/1/2024. (dmr) (Entered: 07/01/2024) (2) |
| Jul 1, 2024 | 257 | ORDER To Unseal. ORDERED that the Clerk shall unseal the following docket entries: D.I. 169-4, 169-6, 169-10, 188-1, 188-2, 188-3, and 188-4, D.I. 218, 218-1, 218-4, and 218-5. Signed by Magistrate Judge Ann Marie Donio on 7/1/2024. (dmr) (Entered: 07/01/2024) (2) |
| Jun 27, 2024 | 254 | Notice to be terminated and withdraw from Notices of Electronic filing as to case. (WALSH, LIZA) (Entered: 06/27/2024) (2) |
| Jun 27, 2024 | 255 | Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney JOHN C. LEDDY terminated. (LEDDY, JOHN) (Entered: 06/27/2024) (2) |
| Jun 26, 2024 | 253 | LETTER ORDER, the above application be and the same is hereby Granted; and it is further ORDERED that Tara M. Raghavan, Esq. is hereby withdrawn as counsel of record for Plaintiffs Mylan Ireland Limited and Mylan Specialty L.P. in this matter. Signed by Magistrate Judge Ann Marie Donio on 6/26/2024. (js) (Entered: 06/27/2024) (2) |
| Jun 25, 2024 | 252 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Approval of Withdrawal of Pro Hac Vice Attorney for Mylan Plaintiffs, Tara M. Raghavan, Esq.. (CALMANN, ARNOLD) (Entered: 06/25/2024) (2) |
| Jun 24, 2024 | 249 | Minute Entry for proceedings held before Magistrate Judge Ann Marie Donio: Telephone Status Conference held on 6/24/2024. Order to be entered. (Court Reporter, Court Conference Line) (sb) (Entered: 06/24/2024) (1) |
| Jun 24, 2024 | 250 | AMENDED SCHEDULING ORDER: Amended Pleadings due by 6/24/2025. Close of Fact Discovery due by 8/8/2025. Signed by Magistrate Judge Ann Marie Donio on 6/24/2024. (tf, ) (Entered: 06/24/2024) (5) |
| Jun 24, 2024 | 251 | TEXT ORDER: The Court will conduct a telephonic status conference on 9/11/2024 at 12:00 Noon. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 105 472 983#. SO ORDERED by Magistrate Judge Ann Marie Donio on 6/24/2024. (slc) (Entered: 06/24/2024) (0) |
| Jun 20, 2024 | 247 | TEXT ORDER: The telephonic status conference on 6/24/2024 at 12:00 Noon shall remain at which time the Court will address the proposed schedule. SO ORDERED by Magistrate Judge Ann Marie Donio on 6/20/2024. (slc) (Entered: 06/20/2024) (0) |
| Jun 20, 2024 | 248 | ORDER, Granting 245 Motion for Leave to Appear Pro Hac Vice as to Dipu Doshi, Esquire and Sydney A. Salters, Esquire. Signed by Magistrate Judge Ann Marie Donio on 6/20/2024. (js) (Entered: 06/20/2024) (4) |
| Jun 18, 2024 | 246 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Enclosing Proposed Amended Scheduling Order and Requesting Adjournment of June 24, 2024 Status Telephone Conference re 244 Order,. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 06/18/2024) (0) |
| Jun 5, 2024 | 245 | MOTION for Leave to Appear Pro Hac Vice by LIFESTAR PHARMA LLC, MANKIND PHARMA LTD.. (Attachments: # 1 Declaration of Michael R. Darbee, Esquire, # 2 Declaration of Dipu Doshi, Esquire, # 3 Declaration of Sydney A. Salters, Esquire, # 4 Text of Proposed Order)(DARBEE, MICHAEL) (Entered: 06/05/2024) (0) |
| May 8, 2024 | 244 | TEXT ORDER: Due to a change in the Court's calendar, the telephonic status conference on 6/18/2024 shall be, and is hereby, RESCHEDULED to 6/24/2024 at 12:00 Noon. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 526 448 69#. SO ORDERED by Magistrate Judge Ann Marie Donio on 5/8/2024. (slc) (Entered: 05/08/2024) (0) |
| Apr 30, 2024 | 243 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. re 233 Order on Motion to Seal Document,,,. (CALMANN, ARNOLD) (Entered: 04/30/2024) (2) |
| Apr 23, 2024 | 241 | STIPULATION AND ORDER Regarding Plaintiff's Motion to Compel Production of CIPLA's API Samples. Signed by Magistrate Judge Ann Marie Donio on 4/23/2024. (dmr) (Entered: 04/23/2024) (4) |
| Apr 23, 2024 | 242 | ORDER to Unseal. ORDERED that, by consent of the parties, the Clerk shall unseal the proposed Order [D.I. 236 ] on the docket. Signed by Magistrate Judge Ann Marie Donio on 4/23/2024. (dmr) (Entered: 04/23/2024) (2) |
| Apr 22, 2024 | 239 | TEXT ORDER: The Court will conduct a telephonic status conference on 6/18/2024 at 2:00 P.M. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 526 448 69#. SO ORDERED by Magistrate Judge Ann Marie Donio on 4/22/2024. (slc) (Entered: 04/22/2024) (0) |
| Apr 22, 2024 | 240 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Unsealing, Execution, and Entry of Stipulation and Proposed Order re 237 Order, 236 Proposed Pretrial Order,,. (CALMANN, ARNOLD) (Entered: 04/22/2024) (1) |
| Apr 15, 2024 | 238 | ORDER granting 217 Motion to Seal 204 Transcript/Digital Recording. Within twenty days of the date of this Order, Cipla shall complete a Statement of Redaction and Sealing and submit such form to the transcription agency in accordance with Local Civil Rule 5.3(g)(2). Signed by Magistrate Judge Ann Marie Donio on 4/15/2024. (jab) (Entered: 04/16/2024) (6) |
| Apr 9, 2024 | 237 | TEXT ORDER: To the extent the parties require a court order in addition to their stipulation [D.I. 236] concerning production of API samples by Cipla, they shall submit a proposed order that the parties do not request be sealed. SO ORDERED by Magistrate Judge Ann Marie Donio on 4/9/2024. (slc) (Entered: 04/09/2024) (0) |
| Apr 8, 2024 | 234 | ORDER Granting Accord and Medichem's 216 Motion to Seal; ORDERED that the First Amended Complaint [D.I. 157 ] shall remain under seal. Signed by Magistrate Judge Ann Marie Donio on 4/8/2024. (dmr) (Entered: 04/08/2024) (6) |
| Apr 8, 2024 | 235 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Enclosing Proposed Stipulation and Order Regarding Cipla's Production of Samples and Requesting Adjournment of April 9, 2024 Telephonic Discovery Conference. (CALMANN, ARNOLD) (Entered: 04/08/2024) (2) |
| Apr 8, 2024 | 236 | Proposed Order --Stipulation and Order-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. re 235 Letter,. (CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 04/08/2024) (4) |
| Apr 2, 2024 | 232 | AMENDED SCHEDULING ORDER: Defendants' deadline to serve their invalidity contentions is extended to 4/18/2024. Defendants' deadline to serve their non-infringement contentions is extended to 4/18/2024. Plaintiffs' deadline to serve their responses to Defendants' invalidity contentions is extended to 7/25/2024. Signed by Magistrate Judge Ann Marie Donio on 4/2/2024. (dmr) (Entered: 04/02/2024) (3) |
| Apr 2, 2024 | 233 | ORDER TO SEAL Granting Defendants' 213 Motion to Seal and Cipla's 226 Motion to Seal; ORDERED that the sealed letters and exhibits filed on the docket at D.I. 169 , 181 , 188 and 218 -2 shall remain under seal. Signed by Magistrate Judge Ann Marie Donio on 4/2/2024. (dmr) (Entered: 04/02/2024) (7) |
| Mar 27, 2024 | 231 | Letter from Loly G. Tor requesting entry of Amended Scheduling Order. (Attachments: # 1 Text of Proposed Order)(TOR, LOLY) (Entered: 03/27/2024) (0) |
| Mar 25, 2024 | 228 | LETTER ORDER Granting request to withdraw the pro hac vice admission of Kurt A. Mathas, Jovial Wong, Alison M. King, Kevin J. Boyle and Annie R. Steiner. Signed by Magistrate Judge Ann Marie Donio on 3/25/2024. (dmr) (Entered: 03/25/2024) (2) |
| Mar 25, 2024 | 229 | TEXT ORDER: The Court will conduct a telephonic discovery conference on 4/5/2024 at 1:30 P.M. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 388 918 954#. SO ORDERED by Magistrate Judge Ann Marie Donio on 3/25/2024. (slc) (Entered: 03/25/2024) (0) |
| Mar 25, 2024 | 230 | AMENDED TEXT ORDER: The Court will conduct a telephonic discovery conference on 4/9/2024 at 3:00 P.M. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 388 918 954#. SO ORDERED by Magistrate Judge Ann Marie Donio on 3/25/2024. (slc) (Entered: 03/25/2024) (0) |
| Mar 24, 2024 | 227 | Letter from Lupin Defendants re withdrawal of pro hac vice counsel. (RICHTER, JAMES) (Entered: 03/24/2024) (2) |
| Mar 20, 2024 | 225 | REDACTION to 218 Letter,, --Redacted Exhibit A-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (CALMANN, ARNOLD) (Entered: 03/20/2024) (6) |
| Mar 20, 2024 | 226 | MOTION to Seal by CIPLA LIMITED, CIPLA USA, INC.. (Attachments: # 1 Certification of Loly G. Tor ISO Defendants' Motion to Seal, # 2 Appendix A Index of Materials to be Sealed, # 3 Text of Proposed Order Granting Defendants' Motion to Seal, # 4 Certificate of Service for Defendants' Motion to Seal)(TOR, LOLY) (Entered: 03/20/2024) (0) |
| Mar 6, 2024 | 224 | Letter from Defendants/Counterclaim-Plaintiffs Cipla Limited and Cipla USA, Inc., in response to Plaintiff's Certification re 219 Exhibit (to Document), 218 Letter,,. (TOR, LOLY) (Entered: 03/06/2024) (2) |
| Feb 29, 2024 | 223 | STIPULATED CONSENT JUDGMENT AND INJUNCTION between Plaintiffs and Defendants Lupin Inc. and Lupin Pharmaceuticals, Inc. The Parties stipulate and agree that all claims, counterclaims, and affirmative defenses asserted by the Parties against each other in the Actions are hereby dismissed without prejudice. Signed by Judge Karen M. Williams on 2/29/2024. (dmr) (Entered: 03/01/2024) (3) |
| Feb 28, 2024 | 222 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Stipulated Consent Judgment and Injunction (Lupin). (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 02/28/2024) (0) |
| Feb 22, 2024 | 220 | Application and Proposed Order for Clerk's Order to extend time to answer as to Lupin Inc's Counterclaims Concerning U.S. Patent No. 11,858,898 (ECF No. 201).. (CALMANN, ARNOLD) (Entered: 02/22/2024) (3) |
| Feb 22, 2024 | 221 | ANSWER to Complaint --Plaintiffs' Answer to Cipla's Counterclaims Concerning U.S. Patent No. 11,858,898 -- See Cipla's Answer, Separate Defenses, and Counterclaims at ECF No. 16 in Civil Action No. 24-00150 by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 02/22/2024) (12) |
| Feb 21, 2024 | 218 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. re 194 Order,. (Attachments: # 1 Certification of Kevin E. Warner, Esq., # 2 Exhibit A, # 3 Exhibit E, # 4 Exhibit F, # 5 Exhibit G)(CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 02/21/2024) (0) |
| Feb 21, 2024 | 219 | Exhibit to 218 Letter,, --Exhibit B to Certification of Kevin E. Warner, Esq.-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Exhibit C, # 2 Exhibit D, # 3 Exhibit H, # 4 Exhibit I)(CALMANN, ARNOLD) (Entered: 02/21/2024) (0) |
| Feb 20, 2024 | 217 | MOTION to Redact and Seal Transcript/Digital Recording 204 Transcript,,, by CIPLA LIMITED, CIPLA USA, INC.. (Attachments: # 1 Certification of Loly G. Tor, # 2 Appendix A, # 3 Text of Proposed Order)(TOR, LOLY) (Entered: 02/20/2024) (0) |
| Feb 16, 2024 | 215 | REDACTION to 157 Amended Complaint,, by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (CALMANN, ARNOLD) (Entered: 02/16/2024) (30) |
| Feb 16, 2024 | 216 | MOTION to Seal a Portion of the Record by ACCORD HEALTHCARE INC.. (Attachments: # 1 Certification of Rebekah Conroy, # 2 Index of Accord Healthcare, Inc., # 3 Certification of John Leddy, # 4 Exhibit of Medichem S.A., # 5 Text of Proposed Order Sealing a Portion of the Record)(CONROY, REBEKAH) (Entered: 02/16/2024) (0) |
| Feb 14, 2024 | 214 | Letter from Accord Healthcare, Inc. to the Honorable Ann Marie Donio, U.S.M.J.. (CONROY, REBEKAH) (Entered: 02/14/2024) (1) |
| Feb 13, 2024 | 210 | REDACTION to 169 Letter,,, by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 REDACTED Exhibit 3, # 2 REDACTED Exhibit 4, # 3 REDACTED Exhibit 7, # 4 REDACTED Exhibit 8, # 5 REDACTED Exhibit 9, # 6 REDACTED Exhibit 10, # 7 REDACTED Exhibit 11, # 8 REDACTED Exhibit 12, # 9 REDACTED Exhibit 13, # 10 REDACTED Exhibit 14, # 11 REDACTED Exhibit 17, # 12 REDACTED Exhibit 20, # 13 UNREDACTED Proposed Order)(CALMANN, ARNOLD) (Entered: 02/13/2024) (0) |
| Feb 13, 2024 | 211 | REDACTION to 188 Letter,, by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 UNREDACTED Exhibit 21, # 2 REDACTED Exhibit 22, # 3 UNREDACTED Exhibit 23, # 4 UNREDACTED Exhibit 24, # 5 REDACTED Exhibit 25)(CALMANN, ARNOLD) (Entered: 02/13/2024) (0) |
| Feb 13, 2024 | 212 | REDACTION to 181 Letter,, by CIPLA LIMITED, CIPLA USA, INC.. (TOR, LOLY) (Entered: 02/13/2024) (30) |
| Feb 13, 2024 | 213 | Joint MOTION to Seal Document 188 Letter,, 181 Letter,, 169 Letter,,, by Defendants Mankind Pharma Ltd, LifeStar Pharma LLC, Lupin Inc., Lupin Pharmaceuticals, Inc., Accord Healthcare, Inc., and by CIPLA LIMITED, CIPLA USA, INC.. (Attachments: # 1 Certification of Loly G. Tor, # 2 Certification of Jay Lessler, # 3 Certification of James S. Richter, # 4 Certification of Rebekah R. Conroy, # 5 Appendix A, # 6 Text of Proposed Order)(TOR, LOLY) (Entered: 02/13/2024) (0) |
| Feb 8, 2024 | 208 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Enclosing Proposed Amended Scheduling Order. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 02/08/2024) (0) |
| Feb 8, 2024 | 209 | AMENDED SCHEDULING ORDER: Defendants' invalidity contentions pursuant to L. Pat. R. 3.6(c), which shall include the United States Patent No. 11,858,898 and disclosures required under L. Pat. R. 3.3, and related production of documents pursuant to L. Pat. R. 3.4(b) and (c) due by 3/28/2024. Signed by Magistrate Judge Ann Marie Donio on 2/8/2024. (dmr) Modified on 2/22/2024 (dmr, ). (Entered: 02/08/2024) (3) |
| Feb 7, 2024 | 206 | LETTER ORDER Granting the request for an extension until 2/13/2024 to submit a motion to seal and file the redacted documents regarding Plaintiffs' December 14, 2023 Letter Application to Compel and supporting exhibits. Signed by Magistrate Judge Ann Marie Donio on 2/7/2024. (dmr) (Entered: 02/07/2024) (2) |
| Feb 7, 2024 | 207 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. re 194 Order,. (CALMANN, ARNOLD) (Entered: 02/07/2024) (1) |
| Feb 6, 2024 | 205 | Letter from Lupin Defendants re extension of deadline to file motion to seal. (RICHTER, JAMES) (Entered: 02/06/2024) (2) |
| Feb 5, 2024 | 204 | Transcript of Telephonic Discovery Conference held on 1/31/2024, before Magistrate Judge Ann Marie Donio. SEALED pursuant to Order 238 . Court Reporter/Transcriber Diana Doman Transcribing, LLC ((856) 435-7172). CLERKS NOTE: This is the complete unredacted/sealed version of the transcript and is unavailable for public viewing. Modified on 4/16/2024 (jab). (Entered: 02/05/2024) (0) |
| Feb 2, 2024 | 203 | ORDER granting 195 Motion for Leave to Appear Pro Hac Vice as to Jenna Bruce, Esquire and Austin R. Rossi, Esquire. Signed by Magistrate Judge Ann Marie Donio on 2/2/2024. (jab) (Entered: 02/02/2024) (2) |
| Feb 1, 2024 | 194 | ORDER regarding discovery. By no later than 2/7/2024, Plaintiffs and Defendant Lupin shall file a letter setting forth the status of production of the closed DMF held by Lupin's third-party API supplier. Signed by Magistrate Judge Ann Marie Donio on 2/1/2024. (dmr) (Entered: 02/01/2024) (1) |
| Feb 1, 2024 | 195 | Consent MOTION for Leave to Appear Pro Hac Vice by Jenna Bruce, Esq. and Austin R. Rossi, Esq., by CIPLA LIMITED, CIPLA USA, INC.. (Attachments: # 1 Certification of Loly G. Tor, # 2 Declaration of Jenna Bruce, # 3 Declaration of Austin R. Rossi, # 4 Text of Proposed Order)(TOR, LOLY) (Entered: 02/01/2024) (0) |
| Feb 1, 2024 | 196 | CONSOLIDATION ORDER. The Actions 23-cv-926 and 24-cv-150 are consolidated for all purposes; ORDERED that all filings in the Consolidated Action shall use the 926 Action caption; ORDERED that Plaintiff shall serve Plaintiff's Disclosure of Asserted Claims of the '898 patent within 48 hours after the submission of this Order. Signed by Judge Karen M. Williams on 2/1/2024. (dmr) (Entered: 02/01/2024) (4) |
| Feb 1, 2024 | 197 | ANSWER to Complaint (ECF No. 1, C.A. No. 1:24-cv-00150) by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC.(MYER, R) (Entered: 02/01/2024) (30) |
| Feb 1, 2024 | 198 | ANSWER to Complaint ECF No. 1, C.A. No. 1:24-cv-00150 by LIFESTAR PHARMA LLC, MANKIND PHARMA LTD..(LESSLER, JAY) (Entered: 02/01/2024) (29) |
| Feb 1, 2024 | 199 | Corporate Disclosure Statement by LIFESTAR PHARMA LLC, MANKIND PHARMA LTD. identifying Mankind Pharma Limited as Corporate Parent.. (LESSLER, JAY) (Entered: 02/01/2024) (3) |
| Feb 1, 2024 | 200 | Third Party Litigation Funding disclosure statement pursuant to L.Civ.R 7.1.1(a)(1-3) filed by LIFESTAR PHARMA LLC, MANKIND PHARMA LTD.. (LESSLER, JAY) (Entered: 02/01/2024) (2) |
| Feb 1, 2024 | 201 | ANSWER to Complaint (in Civil Action No. 24 CV 150), affirmative defenses and, COUNTERCLAIM against All Plaintiffs by LUPIN INC., LUPIN PHARMACEUTICALS, INC..(RICHTER, JAMES) (Entered: 02/01/2024) (30) |
| Feb 1, 2024 | 202 | Corporate Disclosure Statement by LUPIN INC., LUPIN PHARMACEUTICALS, INC.. (RICHTER, JAMES) (Entered: 02/01/2024) (2) |
| Jan 31, 2024 | 191 | ANSWER to Counterclaim of Lupin by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 01/31/2024) (30) |
| Jan 31, 2024 | 192 | ANSWER to Counterclaim of Cipla by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 01/31/2024) (30) |
| Jan 31, 2024 | 193 | Minute Entry for proceedings held before Magistrate Judge Ann Marie Donio: Telephonic Discovery Conference held on 1/31/2024. Telephonic Discovery Conference held on the record. Order to be entered. (Court Reporter, Court Conference Line) (dmr) (Entered: 02/01/2024) (1) |
| Jan 30, 2024 | 190 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Consolidation Order. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 01/30/2024) (0) |
| Jan 23, 2024 | 188 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. re 181 Letter,, 182 Exhibit (to Document), 169 Letter,,,. (Attachments: # 1 Exhibit 21, # 2 Exhibit 22, # 3 Exhibit 23, # 4 Exhibit 24, # 5 Exhibit 25)(CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 01/23/2024) (0) |
| Jan 23, 2024 | 189 | TEXT ORDER: Due to a change in the Court's calendar, the telephonic status/discovery conference on 1/24/2024 shall be, and is hereby, RESCHEDULED to 1/31/2024 at 2:30 P.M. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 124 536 340#. SO ORDERED by Magistrate Judge Ann Marie Donio on 1/23/2024. (slc) (Entered: 01/23/2024) (0) |
| Jan 17, 2024 | 183 | STIPULATED CONSENT JUDGMENT AND INJUNCTION between Plaintiffs and Defendant Orbicular Pharmaceutical Technologies Private Limited. The Parties stipulate and agree that all claims, counterclaims, and affirmative defenses asserted by the Parties against each other in the Action are hereby dismissed without prejudice. Signed by Judge Karen M. Williams on 1/16/2024. (dmr) (Entered: 01/17/2024) (3) |
| Jan 17, 2024 | 184 | ANSWER to Amended Complaint by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC.(MYER, R) (Entered: 01/17/2024) (30) |
| Jan 17, 2024 | 185 | ANSWER to Amended Complaint by MANKIND PHARMA LTD..(LESSLER, JAY) (Entered: 01/17/2024) (30) |
| Jan 17, 2024 | 186 | ANSWER to Amended Complaint , Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by LUPIN INC., LUPIN PHARMACEUTICALS, INC..(RICHTER, JAMES) (Entered: 01/17/2024) (30) |
| Jan 17, 2024 | 187 | ANSWER to Amended Complaint , COUNTERCLAIM against MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. by CIPLA LIMITED, CIPLA USA, INC..(TOR, LOLY) (Entered: 01/17/2024) (30) |
| Jan 12, 2024 | 179 | Stipulated Confidentiality Order. Signed by Magistrate Judge Ann Marie Donio on 1/12/2024. (dmr) (Entered: 01/12/2024) (22) |
| Jan 12, 2024 | 180 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Stipulated Consent Judgment and Injunction (Orbicular). (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 01/12/2024) (0) |
| Jan 12, 2024 | 181 | Letter from Loly G. Tor to the Honorable Ann Marie Donio, U.S.M.J. (Defendants' Responsive Letter) re 178 Order. (Attachments: # 1 Exhibit A, # 2 Exhibit F)(TOR, LOLY)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 01/12/2024) (0) |
| Jan 12, 2024 | 182 | Exhibit to 181 Letter,, (Exhibits B-E) by CIPLA LIMITED, CIPLA USA, INC.. (Attachments: # 1 Exhibit C, # 2 Exhibit D, # 3 Exhibit E)(TOR, LOLY) (Entered: 01/12/2024) (0) |
| Jan 8, 2024 | 178 | LETTER ORDER Granting Defendants' request to submit a responsive letter by January 12, 2024 addressing Plaintiffs' request to file a motion to compel. Signed by Magistrate Judge Ann Marie Donio on 1/8/2024. (dmr) (Entered: 01/08/2024) (2) |
| Jan 3, 2024 | 177 | Letter from Loly G. Tor to the Honorable Ann Marie Donio, U.S.M.J. re 169 Letter,,,. (TOR, LOLY) (Entered: 01/03/2024) (2) |
| Dec 28, 2023 | 176 | STIPULATED CONSENT JUDGMENT AND INJUNCTION: The Parties stipulate and agree that all claims, counterclaims, and affirmative defenses asserted by the Parties against each other in the above-captioned actions are hereby dismissed without prejudice. Signed by Judge Karen M. Williams on 12/28/2023. (jab) (Entered: 12/28/2023) (3) |
| Dec 27, 2023 | 174 | NOTICE of Appearance by JOHN C. LEDDY on behalf of MEDICHEM MANUFACTURING (MALTA) LTD., MEDICHEM S.A., MEDICHEM USA, LLC (LEDDY, JOHN) (Entered: 12/27/2023) (2) |
| Dec 27, 2023 | 175 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Stipulated Consent Judgment aned Injunction (Accord/Medichem).. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 12/27/2023) (0) |
| Dec 19, 2023 | 173 | LETTER ORDER Granting Defendant's 171 consented request for leave to file an omnibus motion to seal, two weeks after the filing of Plaintiffs' answer(s) to Defendants' counterclaims. Signed by Magistrate Judge Ann Marie Donio on 12/19/2023. (mag) (Entered: 12/19/2023) (1) |
| Dec 18, 2023 | 171 | Letter from Accord Healthcare, Inc. re 157 Amended Complaint,,. (CONROY, REBEKAH) (Entered: 12/18/2023) (1) |
| Dec 18, 2023 | 172 | REDACTION to 157 Amended Complaint,, by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (CALMANN, ARNOLD) (Entered: 12/18/2023) (30) |
| Dec 14, 2023 | 166 | WAIVER OF SERVICE Returned Executed by THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN IRELAND LIMITED. MEDICHEM USA, LLC waiver sent on 12/7/2023, answer due 2/5/2024. (CALMANN, ARNOLD) (Entered: 12/14/2023) (1) |
| Dec 14, 2023 | 167 | WAIVER OF SERVICE Returned Executed by THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN IRELAND LIMITED. MEDICHEM S.A. waiver sent on 12/7/2023, answer due 2/5/2024. (CALMANN, ARNOLD) (Entered: 12/14/2023) (1) |
| Dec 14, 2023 | 168 | WAIVER OF SERVICE Returned Executed by THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN IRELAND LIMITED. MEDICHEM MANUFACTURING (MALTA) LTD. waiver sent on 12/7/2023, answer due 2/5/2024. (CALMANN, ARNOLD) (Entered: 12/14/2023) (1) |
| Dec 14, 2023 | 169 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Regarding Plaintiffs' Application to Compel. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 10, # 7 Exhibit 11, # 8 Exhibit 12, # 9 Exhibit 13, # 10 Exhibit 14, # 11 Exhibit 17, # 12 Exhibit 20, # 13 Text of Proposed Order)(CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 12/14/2023) (0) |
| Dec 14, 2023 | 170 | Exhibit to 169 Letter,,, --Exhibit 1-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 5, # 3 Exhibit 6, # 4 Exhibit 15, # 5 Exhibit 16, # 6 Exhibit 18, # 7 Exhibit 19)(CALMANN, ARNOLD) (Entered: 12/14/2023) (0) |
| Dec 12, 2023 | 164 | AO120 Patent/Trademark Form filed. (dmr) (Entered: 12/12/2023) (1) |
| Dec 12, 2023 | 165 | AO120 Patent/Trademark Form filed. (dmr) (Entered: 12/12/2023) (1) |
| Dec 8, 2023 | 162 | AO120 Patent/Trademark Form filed. (dmr) (Entered: 12/08/2023) (1) |
| Dec 8, 2023 | 163 | AO120 Patent/Trademark Form filed. (dmr) (Entered: 12/08/2023) (1) |
| Dec 7, 2023 | 161 | Letter from Arnold B. Calmann, Esq. to the Clerk of the Court Regarding Patent Form AO120 re 5 AO120 Patent/Trademark Form. (CALMANN, ARNOLD) (Entered: 12/07/2023) (2) |
| Dec 6, 2023 | 160 | SUMMONS ON AMENDED COMPLAINT ISSUED as to MEDICHEM MANUFACTURING (MALTA) LTD., MEDICHEM S.A., MEDICHEM USA, LLC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (dmr) (Entered: 12/06/2023) (2) |
| Dec 5, 2023 | 159 | Request for Summons to be Issued by MYLAN IRELAND LIMITED, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN SPECIALTY L.P. as to MEDICHEM MANUFACTURING (MALTA) LTD., MEDICHEM S.A., MEDICHEM USA, LLC. (CALMANN, ARNOLD) (Entered: 12/05/2023) (1) |
| Dec 4, 2023 | 157 | AMENDED COMPLAINT against ACCORD HEALTHCARE, INC., AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., CIPLA LIMITED, CIPLA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, LIFESTAR PHARMA LLC, LUPIN INC., LUPIN PHARMACEUTICALS, INC., MANKIND PHARMA LTD., ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED, MEDICHEM S.A., MEDICHEM MANUFACTURING (MALTA) LTD., MEDICHEM USA, LLC, filed by THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P..(CALMANN, ARNOLD) (Entered: 12/04/2023) (0) |
| Dec 4, 2023 | 158 | Exhibit to 157 Amended Complaint,, --Exhibit A-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Exhibit B, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit F, # 6 Exhibit G, # 7 Exhibit H, # 8 Exhibit I, # 9 Exhibit J, # 10 Exhibit K, # 11 Exhibit L, # 12 Exhibit M)(CALMANN, ARNOLD) (Entered: 12/04/2023) (0) |
| Nov 30, 2023 | 156 | TEXT ORDER: The Court will conduct a telephonic status conference on 1/24/2024 at 11:00 AM. Counsel shall utilize the following dial-in instructions for the conference call: 1-856-210-8988 / 124 536 340#. SO ORDERED by Magistrate Judge Ann Marie Donio on 11/30/2023. (slc) (Entered: 11/30/2023) (0) |
| Nov 29, 2023 | 155 | AMENDED SCHEDULING ORDER: Amended Pleadings due by 12/4/2023. Defendants' deadline to serve amended Answers and Counterclaims to Plaintiffs' Amended Complaint is 1/17/2024. Signed by Magistrate Judge Ann Marie Donio on 11/29/2023. (dmr) (Entered: 11/29/2023) (5) |
| Nov 17, 2023 | 154 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Enclosing Proposed Amended Scheduling Order re 148 Order,. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 11/17/2023) (0) |
| Nov 16, 2023 | 153 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Enclosing Proposed Stipulated Confidentiality Order. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 11/16/2023) (0) |
| Nov 15, 2023 | 152 | Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney SURINDER K. AGGARWAL terminated. (AGGARWAL, SURINDER) (Entered: 11/15/2023) (2) |
| Nov 8, 2023 | 151 | Transcript of Telephone Status Conference held on 11/1/2023, before Magistrate Judge Ann Marie Donio. Court Reporter/Transcriber Diana Doman Transcribing, LLC ((856) 435-7172). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter/Transcription Agency due, but not filed, by 11/29/2023. Redacted Transcript Deadline set for 12/11/2023. Release of Transcript Restriction set for 2/6/2024. (mag) (Entered: 11/08/2023) (11) |
| Nov 3, 2023 | 150 | ANSWER to Counterclaim Plaintiffs' Answer to Accord's Counterclaims Regarding U.S. Patent No. 11,691,948 by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 11/03/2023) (9) |
| Nov 1, 2023 | 144 | Notice to be terminated and withdraw from Notices of Electronic filing as to case. (WALSH, LIZA) (Entered: 11/01/2023) (2) |
| Nov 1, 2023 | 145 | Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney CHRISTINE INTROMASSO GANNON terminated. (GANNON, CHRISTINE) (Entered: 11/01/2023) (2) |
| Nov 1, 2023 | 146 | Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney JESSICA K. FORMICHELLA terminated. (FORMICHELLA, JESSICA) (Entered: 11/01/2023) (2) |
| Nov 1, 2023 | 147 | Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney LIZA M. WALSH terminated. (WALSH, LIZA) (Entered: 11/01/2023) (2) |
| Nov 1, 2023 | 148 | TEXT ORDER: As set forth on the record on November 1, 2023, Plaintiffs shall file a revised proposed Discovery Confidentiality Order and a revised proposed scheduling order by no later than November 17, 2023. SO ORDERED by Magistrate Judge Ann Marie Donio on 11/1/2023. (slc) (Entered: 11/01/2023) (0) |
| Nov 1, 2023 | 149 | Minute Entry for proceedings held before Magistrate Judge Ann Marie Donio: Telephone Status Conference held on 11/1/2023. Telephone Status Conference held on the record. Ordered that plaintiffs shall submit a revised proposed Discovery Confidentiality Order and a revised proposed schedule by November 17, 2023. Order to be entered. (Court Reporter, Court Conference Line) (dmr) (Entered: 11/01/2023) (1) |
| Oct 31, 2023 | 141 | MOTION for Leave to Appear Pro Hac Vice by LIFESTAR PHARMA LLC, MANKIND PHARMA LTD.. (Attachments: # 1 Declaration of Michael R. Darbee, # 2 Declaration of Joshua S. Reisberg, # 3 Text of Proposed Order)(DARBEE, MICHAEL) (Entered: 10/31/2023) (0) |
| Oct 31, 2023 | 142 | ORDER granting 141 Motion for Leave to Appear Pro Hac Vice as to Joshua S. Reisberg, Esquire. Signed by Magistrate Judge Ann Marie Donio on 10/31/2023. (jab) (Entered: 10/31/2023) (3) |
| Oct 31, 2023 | 143 | STIPULATED CONSENT JUDGMENT AND INJUNCTION. The Parties stipulate and agree that all claims, counterclaims, and affirmative defenses asserted by the Parties against each other in the above-captioned Actions are hereby dismissed without prejudice. Signed by Judge Karen M. Williams on 10/31/2023. (dmR) (Entered: 10/31/2023) (3) |
| Oct 30, 2023 | 138 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Stipulated Consent Judgment aned Injunction (Teva). (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 10/30/2023) (0) |
| Oct 30, 2023 | 139 | TEXT ORDER: The in-person hearing on 11/1/2023 at 12:30 P.M. shall be, and is hereby, CONVERTED to a TELEPHONIC hearing. Counsel shall utilize the following dial-in instructions for the conference call: 1-888-684-8852 / 2828702# / 654321#. SO ORDERED by Magistrate Judge Ann Marie Donio on 10/30/2023. (slc) (Entered: 10/30/2023) (0) |
| Oct 30, 2023 | 140 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. (Joint Status Letter Regarding DCO Disputes). (CALMANN, ARNOLD) (Entered: 10/30/2023) (3) |
| Oct 27, 2023 | 136 | ANSWER to Complaint Plaintiffs' Answer to Lupin Inc.'s Counterclaims Regarding U.S. Patent No. 11,691,948 -- See Lupin's Answer, Affirmative Defenses, and Counterclaims for Declaratory Judgment at ECF No. 25 in Civil Action No. 23-06667 by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 10/27/2023) (11) |
| Oct 27, 2023 | 137 | ANSWER to Complaint Plaintiffs' Answer to Cipla's Counterclaims Regarding U.S. Patent No. 11,691,948 -- See Cipla's Answer, Separate Defenses, and Counterclaims at ECF No. 27 in Civil Action No. 23-06667 by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 10/27/2023) (12) |
| Oct 23, 2023 | 135 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. (Joint Status Letter) re 133 Order, Set Hearings, 130 Order, Set Hearings. (CALMANN, ARNOLD) (Entered: 10/23/2023) (4) |
| Oct 19, 2023 | 134 | Application and Proposed Order for Clerk's Order to extend time to answer as to Accord's Counterclaims (ECF No. 126) and Teva's Counterclaims (ECF No. 128).. (CALMANN, ARNOLD) (Entered: 10/19/2023) (4) |
| Oct 13, 2023 | 133 | ORDER RESCHEDULING the October 24, 2023 in person hearing to 11/1/2023 at 12:30 PM in Camden - Courtroom 3B before Magistrate Judge Ann Marie Donio. Signed by Magistrate Judge Ann Marie Donio on 10/13/2023. (dmr) (Entered: 10/13/2023) (1) |
| Oct 12, 2023 | 132 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Rescheduling of October 24, 2023 In-Person Hearing re 130 Order, Set Hearings. (CALMANN, ARNOLD) (Entered: 10/12/2023) (2) |
| Oct 10, 2023 | 131 | Application and Proposed Order for Clerk's Order to extend time to answer as to Lupin's Counterclaims for Declaratory Judgment (ECF No. 25 in Civil Action No. 23-cv-06667) and Cipla's Counterclaims (ECF No. 27 in Civil Action No. 23-cv-06667).. (CALMANN, ARNOLD) (Entered: 10/10/2023) (3) |
| Oct 6, 2023 | 129 | Transcript of Telephonic Discovery and Status Conference held on 10/3/2023, before Magistrate Judge Ann Marie Donio. Court Reporter/Transcriber Diana Doman Transcribing, LLC ((856) 435-7172). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter/Transcription Agency due, but not filed, by 10/27/2023. Redacted Transcript Deadline set for 11/6/2023. Release of Transcript Restriction set for 1/4/2024. (mag) (Entered: 10/06/2023) (21) |
| Oct 6, 2023 | 130 | ORDER regarding discovery deadlines. The Court will conduct an in-person hearing on 10/24/2023 at 11:00 AM in Camden - Courtroom 3B before Magistrate Judge Ann Marie Donio. Signed by Magistrate Judge Ann Marie Donio on 10/6/2023. (dmr) (Entered: 10/06/2023) (2) |
| Oct 4, 2023 | 128 | ANSWER to Complaint , COUNTERCLAIM against All Plaintiffs by TEVA PHARMACEUTICALS, INC., TEVA PHARMACEUTICALS USA, INC..(WALSH, LIZA) (Entered: 10/04/2023) (30) |
| Oct 3, 2023 | 127 | Minute Entry for proceedings held before Magistrate Judge Ann Marie Donio: Telephonic Discovery and Status Conference held on 10/3/2023. Telephonic Discovery and Status Conference held on the record. Order to be entered. (Court Reporter, ECR) (dmr) (Entered: 10/03/2023) (1) |
| Sep 29, 2023 | 125 | CONSOLIDATION ORDER. ORDERED that Civil Actions 23-926 and 23-6667 are consolidated for all purposes; ORDERED that all filings in the Consolidated Actions shall use the 23-926 Action caption; ORDERED that all filings going forward shall be filed in the 23-926 Action and that the 23-6667 Action shall be administratively terminated. Signed by Judge Karen M. Williams on 9/28/2023. (dmr) (Entered: 09/29/2023) (3) |
| Sep 29, 2023 | 126 | DEFENDANT ACCORD HEALTHCARE, INC.'S ANSWER to Complaint , Affirmative Defenses and, COUNTERCLAIM against MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. by ACCORD HEALTHCARE, INC..(CONROY, REBEKAH) (Entered: 09/29/2023) (30) |
| Sep 27, 2023 | 124 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Regarding Parties' Joint Status Letter re 117 Scheduling Order, 122 Letter,. (CALMANN, ARNOLD) (Entered: 09/27/2023) (6) |
| Sep 25, 2023 | 123 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Consolidation Order. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 09/25/2023) (0) |
| Sep 20, 2023 | 122 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Regarding Proposed Confidentiality Order. (Attachments: # 1 Exhibit 1 -- Proposed Confidentiality Order, # 2 Exhibit 2 -- Redline of Proposed Confidentiality Order as Compared to Appendix S)(CALMANN, ARNOLD) (Entered: 09/20/2023) (0) |
| Sep 19, 2023 | 121 | LETTER ORDER Granting request for an extension of time, to 9/20/2023, to submit the Confidentiality Order. Signed by Magistrate Judge Ann Marie Donio on 9/19/2023. (dmr) (Entered: 09/19/2023) (2) |
| Sep 18, 2023 | 120 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Two-Day Extension to Submit Confidentiality Order. (CALMANN, ARNOLD) (Entered: 09/18/2023) (2) |
| Aug 31, 2023 | 119 | LETTER ORDER Granting the parties' request for an extension of time, to 9/18/2023, to submit the Confidentiality Order. Signed by Magistrate Judge Ann Marie Donio on 8/31/2023. (dmr) (Entered: 08/31/2023) (2) |
| Aug 30, 2023 | 118 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J., Regarding Joint Request for Extension of Time to File Confidentiality Order. (CALMANN, ARNOLD) (Entered: 08/30/2023) (2) |
| Aug 16, 2023 | 117 | SCHEDULING ORDER ON CONSENT: Telephone Status Conference set for 10/3/2023 at 2:00 PM before Magistrate Judge Ann Marie Donio. Signed by Magistrate Judge Ann Marie Donio on 8/16/2023. (jab) (Entered: 08/17/2023) (4) |
| Aug 4, 2023 | 115 | Letter from R Touhey Myer to the Honorable Ann Marie Donio, U.S.M.J. re Request for Extension of Time. (MYER, R) (Entered: 08/04/2023) (1) |
| Aug 4, 2023 | 116 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Enclosing Proposed Scheduling Order On Consent. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 08/04/2023) (0) |
| Aug 1, 2023 | 114 | Transcript of Status Conference held on 7/27/2023, before Magistrate Judge Ann Marie Donio. Court Reporter/Transcriber Diana Doman Transcribing, LLC ((856) 435-7172). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter/Transcription Agency due, but not filed, by 8/22/2023. Redacted Transcript Deadline set for 9/1/2023. Release of Transcript Restriction set for 10/30/2023. (mag) (Entered: 08/01/2023) (44) |
| Jul 27, 2023 | 112 | TEXT ORDER: Michael Darbee, Esquire, counsel for Mankind Pharma Ltd. and Lifestar Pharma LLC, shall be, and is hereby, permitted to appear via telephone for the initial scheduling conference on 7/27/2023. Counsel shall utilize the following dial-in instructions for the conference: 1-888-684-8852 / 2828702# / 654321#. SO ORDERED by Magistrate Judge Ann Marie Donio on 7/27/2023. (slc) (Entered: 07/27/2023) (0) |
| Jul 27, 2023 | 113 | Minute Entry for proceedings held before Magistrate Judge Ann Marie Donio: Initial Scheduling Conference held on 7/27/2023. Initial Scheduling Conference held on the record. Consent Order to be submitted. (Court Reporter, ECR) (dmr) (Entered: 07/27/2023) (1) |
| Jul 26, 2023 | 111 | NOTICE of Appearance by SURINDER K. AGGARWAL on behalf of ACCORD HEALTHCARE, INC. (AGGARWAL, SURINDER) (Entered: 07/26/2023) (2) |
| Jul 20, 2023 | 110 | Joint Discovery Plan by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 07/20/2023) (27) |
| Jun 28, 2023 | N/A | Pro Hac Vice counsel, MARY W. BURKE, DANA K. SEVERANCE, JOHN B. BOURKE, WILLIAM A. RAKOCZY, JOSEPH T. JAROS, KEVIN E. WARNER, MATTHEW V. ANDERSON, TARA M. RAGHAVAN, NICHOLAS D. BORTZ and DANIEL SOKOLOFF, have been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (dmr) (Entered: 06/28/2023) (0) |
| Jun 27, 2023 | N/A | Pro Hac Vice counsel, KRISTIN M. BEALE, ELAINE HERRMANN BLAIS and ERIC T. ROMEO, have been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (dmr) (Entered: 06/27/2023) (0) |
| Jun 27, 2023 | N/A | Set/Reset Deadlines as to 98 Consent MOTION for Leave to Appear Pro Hac Vice of Mary W. Bourke, Esq., Dana K. Severance, John B. Bourke, Esq., William A. Rakoczy, Esq., Joseph T. Jaros, Esq., Kevin E. Warner, Esq., Matthew V. Anderson, Esq., Tara M. Raghavan, Esq., Nicholas D. Bortz, Esq., Daniel Sokoloff, Esq. Motion set for 8/7/2023 before Magistrate Judge Ann Marie Donio. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (dmr) (Entered: 06/27/2023) (0) |
| Jun 27, 2023 | 99 | ORDER granting 98 Motion for Leave to Appear Pro Hac Vice as to Mary Bourke, Esq., Dana Severance, Esq., Ben Bourke, Esq., William A. Rakoczy, Esq., Kevin E. Warner, Esq., Joseph T. Jaros, Esq., Matthew V. Anderson, Esq., Tara M. Raghavan, Esq., Nicholas D, Bortz, Esq., and Daniel Sokoloff, Esq. Signed by Magistrate Judge Ann Marie Donio on 6/27/2023. (dmr) (Entered: 06/27/2023) (4) |
| Jun 27, 2023 | 100 | Notice of Request by Pro Hac Vice Mary W. Bourke, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14418965.) (CALMANN, ARNOLD) (Entered: 06/27/2023) (2) |
| Jun 27, 2023 | 101 | Notice of Request by Pro Hac Vice Dana K. Severance, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14418967.) (CALMANN, ARNOLD) (Entered: 06/27/2023) (2) |
| Jun 27, 2023 | 102 | Notice of Request by Pro Hac Vice John B. Bourke, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14418969.) (CALMANN, ARNOLD) (Entered: 06/27/2023) (2) |
| Jun 27, 2023 | 103 | Notice of Request by Pro Hac Vice William A. Rakoczy, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14418970.) (CALMANN, ARNOLD) (Entered: 06/27/2023) (2) |
| Jun 27, 2023 | 104 | Notice of Request by Pro Hac Vice Joseph T. Jaros, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14418975.) (CALMANN, ARNOLD) (Entered: 06/27/2023) (2) |
| Jun 27, 2023 | 105 | Notice of Request by Pro Hac Vice Kevin E. Warner, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14418976.) (CALMANN, ARNOLD) (Entered: 06/27/2023) (2) |
| Jun 27, 2023 | 106 | Notice of Request by Pro Hac Vice Matthew V. Anderson, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14418981.) (CALMANN, ARNOLD) (Entered: 06/27/2023) (2) |
| Jun 27, 2023 | 107 | Notice of Request by Pro Hac Vice Tara M. Raghavan, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14418983.) (CALMANN, ARNOLD) (Entered: 06/27/2023) (2) |
| Jun 27, 2023 | 108 | Notice of Request by Pro Hac Vice Nicholas D. Bortz, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14418984.) (CALMANN, ARNOLD) (Entered: 06/27/2023) (2) |
| Jun 27, 2023 | 109 | Notice of Request by Pro Hac Vice Daniel Sokoloff, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14418987.) (CALMANN, ARNOLD) (Entered: 06/27/2023) (2) |
| Jun 26, 2023 | 94 | CONSOLIDATION ORDER. ORDERED that Civil Action 23-926 and 23-2843 are consolidated for all purposes; ORDERED that all filings going forward shall be filed in the 23-926 Action and that the 23-2843 Action shall be administratively terminated. Signed by Judge Karen M. Williams on 6/23/2023. (dmr) (Entered: 06/26/2023) (3) |
| Jun 26, 2023 | 95 | Notice of Request by Pro Hac Vice Kristin M. Beale to receive Notices of Electronic Filings. (WALSH, LIZA) (Entered: 06/26/2023) (2) |
| Jun 26, 2023 | 96 | Notice of Request by Pro Hac Vice Elaine Herrmann Blais to receive Notices of Electronic Filings. (WALSH, LIZA) (Entered: 06/26/2023) (2) |
| Jun 26, 2023 | 97 | Notice of Request by Pro Hac Vice Eric. T. Romeo to receive Notices of Electronic Filings. (WALSH, LIZA) (Entered: 06/26/2023) (2) |
| Jun 26, 2023 | 98 | Consent MOTION for Leave to Appear Pro Hac Vice of Mary W. Bourke, Esq., Dana K. Severance, John B. Bourke, Esq., William A. Rakoczy, Esq., Joseph T. Jaros, Esq., Kevin E. Warner, Esq., Matthew V. Anderson, Esq., Tara M. Raghavan, Esq., Nicholas D. Bortz, Esq., and Daniel Sokoloff, Esq. by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (Attachments: # 1 Certification of Arnold B. Calmann, Esq., # 2 Declaration of Mary W. Bourke, Esq., # 3 Declaration of Dana K. Severance, Esq., # 4 Declaration of John B. Bourke, Esq., # 5 Declaration of William A. Rakoczy, Esq., # 6 Declaration of Joseph T. Jaros, Esq., # 7 Declaration of Kevin E. Warner, Esq., # 8 Declaration of Matthew V. Anderson, Esq., # 9 Declaration of Tara M. Raghavan, Esq., # 10 Declaration of Nicholas D. Bortz, Esq., # 11 Declaration of Daniel Sokoloff, Esq., # 12 Text of Proposed Order, # 13 Certificate of Service)(CALMANN, ARNOLD) (Entered: 06/26/2023) (0) |
| Jun 22, 2023 | N/A | Pro Hac Vice fee received as to Elaine Herrmann Blais, Eric T. Romeo and Kristin M. Beale $ 450.00 receipt number TRE133231 (kht) (Entered: 06/22/2023) (0) |
| Jun 22, 2023 | 93 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J., Enclosing Proposed Consolidation Order. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 06/22/2023) (0) |
| Jun 21, 2023 | 87 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. re 86 Letter. (CALMANN, ARNOLD) (Entered: 06/21/2023) (1) |
| Jun 21, 2023 | 88 | ANSWER to Counterclaim of Teva Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc. by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 06/21/2023) (19) |
| Jun 21, 2023 | 89 | ANSWER to Counterclaim of Lupin Inc. by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 06/21/2023) (21) |
| Jun 21, 2023 | 90 | ANSWER to Counterclaim of Accord Healthcare, Inc. by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 06/21/2023) (16) |
| Jun 21, 2023 | 91 | ANSWER to Counterclaim of Cipla Limited and Cipla USA Inc. by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(CALMANN, ARNOLD) (Entered: 06/21/2023) (21) |
| Jun 21, 2023 | 92 | CERTIFICATE OF SERVICE by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. re 90 Answer to Counterclaim, 89 Answer to Counterclaim, 88 Answer to Counterclaim, 91 Answer to Counterclaim (CALMANN, ARNOLD) (Entered: 06/21/2023) (2) |
| Jun 16, 2023 | 85 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Regarding Joinder re 81 Status Conference,. (CALMANN, ARNOLD) (Entered: 06/16/2023) (2) |
| Jun 16, 2023 | 86 | Letter from Liza M. Walsh to the Honorable Ann Marie Donio, U.S.M.J. (WALSH, LIZA) (Entered: 06/16/2023) (2) |
| Jun 15, 2023 | 84 | CONSENT ORDER Correcting Typographical Error in Pleadings and Amending Caption. ORDERED that the typographical error in the Complaint, Eugia's Answer, Eugia's Corporate Disclosure Statement, and all pleadings on file naming "Eugia Pharma Specialties Ltd." as the party defendant be corrected to "Eugia Pharma Specialities Ltd. Signed by Magistrate Judge Ann Marie Donio on 6/14/2023. (dmr) (Entered: 06/15/2023) (3) |
| Jun 13, 2023 | 83 | Transcript of Telephone Status Conference held on 6/7/2023, before Judge Donio. Court Reporter/Transcriber Diana Doman Transcribing, LLC (856-435-7172). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter/Transcription Agency due, but not filed, by 7/5/2023. Redacted Transcript Deadline set for 7/14/2023. Release of Transcript Restriction set for 9/11/2023. (js) (Entered: 06/13/2023) (0) |
| Jun 12, 2023 | 82 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Enclosing Proposed Consent Order. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 06/12/2023) (0) |
| Jun 7, 2023 | 79 | TEXT ORDER: As set forth on the record on June 7, 2023, Plaintiffs, as well as any other party that seeks to address the issue, shall submit letters concerning the joinder issue by no later than June 16, 2023. SO ORDERED by Magistrate Judge Ann Marie Donio on 6/7/2023. (slc) (Entered: 06/07/2023) (0) |
| Jun 7, 2023 | 80 | TEXT ORDER: The Court will conduct the initial scheduling conference on 7/27/2023 at 11:00 A.M. in Courtroom 3B, Mitchell H. Cohen U.S. Courthouse, Fourth and Cooper Streets, Camden, New Jersey. The joint discovery plan shall either be filed on the docket, or alternatively, emailed to the Court at njdnef_donio@njd.uscourts.gov. SO ORDERED by Magistrate Judge Ann Marie Donio on 6/7/2023. (slc) (Entered: 06/07/2023) (0) |
| Jun 7, 2023 | 81 | Minute Entry for proceedings held before Magistrate Judge Ann Marie Donio: Telephone Status Conference held on 6/7/2023. Telephone Status Conference held on the record. Ordered any further submissions re: joinder issue to be submitted by 6/16/2023. Order to be entered. (Court Reporter, ECR) (dmr) (Entered: 06/07/2023) (1) |
| Jun 6, 2023 | N/A | Clerk`s Text Order - The document 78 Application for Clerk's Order to Ext Answer/Proposed Order submitted by THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P. has been GRANTED. The answer due date has been set for 6/21/2023. (mag) (Entered: 06/06/2023) (0) |
| Jun 5, 2023 | 78 | Application and Proposed Order for Clerk's Order to extend time to answer as to Defendants' Counterclaims.. (CALMANN, ARNOLD) (Entered: 06/05/2023) (4) |
| May 30, 2023 | 73 | Notice of Request by Pro Hac Vice Timothy H. Kratz to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14348717.) (MYER, R) (Entered: 05/30/2023) (2) |
| May 30, 2023 | 74 | Notice of Request by Pro Hac Vice Michael P. Hogan to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14348720.) (MYER, R) (Entered: 05/30/2023) (2) |
| May 30, 2023 | N/A | Pro Hac Vice counsel, KURT A. MATHAS, JOVIAL WONG, ANNIE R. STEINER, KEVIN J. BOYLE and ALISON M. KING, have been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (dmr) (Entered: 05/30/2023) (0) |
| May 30, 2023 | 75 | Notice of Request by Pro Hac Vice Alejandro Menchaca, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14349183.) (CONROY, REBEKAH) (Entered: 05/30/2023) (2) |
| May 30, 2023 | 76 | Notice of Request by Pro Hac Vice Bradley Loren, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14349196.) (CONROY, REBEKAH) (Entered: 05/30/2023) (2) |
| May 30, 2023 | 77 | Notice of Request by Pro Hac Vice Ben Mahon, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14349209.) (CONROY, REBEKAH) (Entered: 05/30/2023) (2) |
| May 30, 2023 | N/A | Pro Hac Vice counsel, TIMOTHY H. KRATZ, ALEJANDRO MENCHACA, MICHAEL P. HOGAN, BRADLEY LOREN and BEN MAHON, have been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (dmr) (Entered: 05/30/2023) (0) |
| May 26, 2023 | 68 | Notice of Request by Pro Hac Vice Kurt A. Mathas to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14347214.) (RICHTER, JAMES) (Entered: 05/26/2023) (2) |
| May 26, 2023 | 69 | Notice of Request by Pro Hac Vice Jovial Wong to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14347220.) (RICHTER, JAMES) (Entered: 05/26/2023) (2) |
| May 26, 2023 | 70 | Notice of Request by Pro Hac Vice Annie R. Steiner to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14347226.) (RICHTER, JAMES) (Entered: 05/26/2023) (2) |
| May 26, 2023 | 71 | Notice of Request by Pro Hac Vice Kevin Boyle to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14347230.) (RICHTER, JAMES) (Entered: 05/26/2023) (2) |
| May 26, 2023 | 72 | Notice of Request by Pro Hac Vice Alison M. King to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14347236.) (RICHTER, JAMES) (Entered: 05/26/2023) (2) |
| May 25, 2023 | N/A | Pro Hac Vice counsel, ANIL H. PATEL, HAROLD STOREY, DEVON C. BEANE and EWA A. WOJCIECHOWSKA, have been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (dmr) (Entered: 05/25/2023) (0) |
| May 25, 2023 | N/A | Set/Reset Deadlines as to 62 MOTION for Leave to Appear Pro Hac Vice with Consent of Plaintiffs. Motion set for 6/20/2023 before Magistrate Judge Ann Marie Donio. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (dmr) (Entered: 05/25/2023) (0) |
| May 25, 2023 | 67 | ORDER granting 62 Motion for Leave to Appear Pro Hac Vice as to Alejandro Menchaca, Esq., Ben J, Mahon, Esq., and Bradley P. Loren, Esq. Signed by Magistrate Judge Ann Marie Donio on 5/25/2023. (dmr) (Entered: 05/25/2023) (3) |
| May 24, 2023 | N/A | Set/Reset Deadlines as to 56 Consent MOTION for Leave to Appear Pro Hac Vice , 59 MOTION for Leave to Appear Pro Hac Vice with Consent. Motion set for 6/20/2023 before Magistrate Judge Ann Marie Donio. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (dmr) (Entered: 05/24/2023) (0) |
| May 24, 2023 | 60 | ORDER granting 56 Motion for Leave to Appear Pro Hac Vice as to Kurt A. Mathas, Jovial Wong, Alison M. King, Kevin J. Boyle and Annie R. Steiner. Signed by Magistrate Judge Ann Marie Donio on 5/23/2023. (dmr) (Entered: 05/24/2023) (3) |
| May 24, 2023 | 61 | ORDER granting 59 Motion for Leave to Appear Pro Hac Vice as to Timothy H. Kratz and Michael P. Hogan. Signed by Magistrate Judge Ann Marie Donio on 5/24/2023. (dmr) (Entered: 05/24/2023) (2) |
| May 24, 2023 | 62 | MOTION for Leave to Appear Pro Hac Vice with Consent of Plaintiffs by ACCORD HEALTHCARE, INC.. (Attachments: # 1 Certification of Rebekah Conroy, # 2 Certification of Alejandro Menchaca, # 3 Certification of Ben J. Mahon, # 4 Certification of Bradley P. Loren, # 5 Text of Proposed Order Admitting Counsel Pro Hac Vice on Consent)(CONROY, REBEKAH) (Entered: 05/24/2023) (0) |
| May 24, 2023 | 63 | Notice of Request by Pro Hac Vice Anil H. Patel to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14342245.) (TOR, LOLY) (Entered: 05/24/2023) (1) |
| May 24, 2023 | 64 | Notice of Request by Pro Hac Vice Harold Storey to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14342256.) (TOR, LOLY) (Entered: 05/24/2023) (1) |
| May 24, 2023 | 65 | Notice of Request by Pro Hac Vice Devon C. Beane to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14342258.) (TOR, LOLY) (Entered: 05/24/2023) (1) |
| May 24, 2023 | 66 | Notice of Request by Pro Hac Vice Ewa A. Wojciechowska to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14342261.) (TOR, LOLY) (Entered: 05/24/2023) (1) |
| May 23, 2023 | N/A | Set/Reset Deadlines as to 55 Consent MOTION for Leave to Appear Pro Hac Vice for Anil H. Patel, Harold Storey, Devon C. Beane, and Ewa A. Wojciechowska. Motion set for 6/20/2023 before Magistrate Judge Ann Marie Donio. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (dmr, ) (Entered: 05/23/2023) (0) |
| May 23, 2023 | 56 | Consent MOTION for Leave to Appear Pro Hac Vice by LUPIN INC., LUPIN PHARMACEUTICALS, INC.. (Attachments: # 1 Declaration of James Richter, # 2 Declaration of J. Wong, # 3 Declaration of K. Mathas, # 4 Declaration of K. Boyle, # 5 Declaration of A. King, # 6 Declaration of A. Steiner, # 7 Text of Proposed Order)(RICHTER, JAMES) (Entered: 05/23/2023) (0) |
| May 23, 2023 | 57 | ORDER granting 55 Motion for Leave to Appear Pro Hac Vice as to Anil H. Patel, Esq., Harold Storey, Esq., Devon C. Beane, Esq., and Ewa A. Wojciechowska, Esq.. Signed by Magistrate Judge Ann Marie Donio on 5/23/2023. (dmr) (Entered: 05/23/2023) (3) |
| May 23, 2023 | 58 | NOTICE of Appearance by R TOUHEY MYER on behalf of AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC (MYER, R) (Entered: 05/23/2023) (3) |
| May 23, 2023 | 59 | MOTION for Leave to Appear Pro Hac Vice with Consent by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC. (Attachments: # 1 Certification of R Touhey Myer, # 2 Certification of Timothy H. Kratz, # 3 Certification of Michael P. Hogan, # 4 Statement in Lieu of Brief, # 5 Text of Proposed Order, # 6 Certificate of Service)(MYER, R) (Entered: 05/23/2023) (0) |
| May 22, 2023 | 55 | Consent MOTION for Leave to Appear Pro Hac Vice for Anil H. Patel, Harold Storey, Devon C. Beane, and Ewa A. Wojciechowska by CIPLA LIMITED, CIPLA USA, INC.. (Attachments: # 1 Certification of Loly G. Tor, # 2 Declaration of Anil H. Patel, # 3 Declaration of Harold Storey, # 4 Declaration Devon C. Beane, # 5 Declaration Ewa A. Wojciechowska, # 6 Text of Proposed Order)(TOR, LOLY) (Entered: 05/22/2023) (0) |
| May 19, 2023 | N/A | Pro Hac Vice counsel, RONALD M. DAIGNAULT and RICHARD JUANG, have been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (dmr) (Entered: 05/19/2023) (0) |
| May 18, 2023 | 52 | ORDER granting 41 Motion for Leave to Appear Pro Hac Vice as to Ronald M. Daignault and Richard Juang. Signed by Magistrate Judge Ann Marie Donio on 5/18/2023. (dmr) (Entered: 05/18/2023) (3) |
| May 18, 2023 | 53 | Notice of Request by Pro Hac Vice Ronald M. Daignault to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14327046.) (VAN BUSKIRK, TEDD) (Entered: 05/18/2023) (1) |
| May 18, 2023 | 54 | Notice of Request by Pro Hac Vice Richard Juang to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14327069.) (VAN BUSKIRK, TEDD) (Entered: 05/18/2023) (1) |
| May 17, 2023 | 39 | ANSWER to Complaint by ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED.(VAN BUSKIRK, TEDD) (Entered: 05/17/2023) (29) |
| May 17, 2023 | 40 | Corporate Disclosure Statement by ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED identifying Orbicular Pharmaceutical Technologies Private Limited as Corporate Parent.. (VAN BUSKIRK, TEDD) (Entered: 05/17/2023) (3) |
| May 17, 2023 | 41 | MOTION for Leave to Appear Pro Hac Vice by ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED. (Attachments: # 1 Certification Ron Daignault, # 2 Certification Richard Juang, # 3 Certification Tedd Van Buskirk, # 4 Statement, # 5 Text of Proposed Order)(VAN BUSKIRK, TEDD) (Entered: 05/17/2023) (0) |
| May 17, 2023 | N/A | Set/Reset Deadlines as to 41 MOTION for Leave to Appear Pro Hac Vice . Motion set for 6/20/2023 before Magistrate Judge Ann Marie Donio. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (dmr) (Entered: 05/17/2023) (0) |
| May 17, 2023 | 42 | ANSWER to Complaint by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC.(MYER, R) (Entered: 05/17/2023) (30) |
| May 17, 2023 | 43 | Corporate Disclosure Statement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC identifying Aurobindo Pharma Limited, Mviyes Pharma Ventures Private Limited and Eugia Pharma Specialties Ltd. as Corporate Parent.. (MYER, R) (Entered: 05/17/2023) (3) |
| May 17, 2023 | 44 | ANSWER to Complaint , COUNTERCLAIM against MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. by TEVA PHARMACEUTICALS, INC., TEVA PHARMACEUTICALS USA, INC..(WALSH, LIZA) (Entered: 05/17/2023) (30) |
| May 17, 2023 | 45 | Corporate Disclosure Statement by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (WALSH, LIZA) (Entered: 05/17/2023) (2) |
| May 17, 2023 | 46 | ANSWER to Complaint , Affirmative Defenses and Lupin Inc.'s, COUNTERCLAIM against All Plaintiffs by LUPIN INC., LUPIN PHARMACEUTICALS, INC..(RICHTER, JAMES) (Entered: 05/17/2023) (30) |
| May 17, 2023 | 47 | Corporate Disclosure Statement by LUPIN INC., LUPIN PHARMACEUTICALS, INC.. (RICHTER, JAMES) (Entered: 05/17/2023) (2) |
| May 17, 2023 | 48 | DEFENDANT ACCORD HEALTHCARE, INC.'S ANSWER to Complaint , Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by ACCORD HEALTHCARE, INC..(CONROY, REBEKAH) (Entered: 05/17/2023) (30) |
| May 17, 2023 | 49 | Corporate Disclosure Statement by ACCORD HEALTHCARE, INC. identifying Accord Healthcare, Inc. as Corporate Parent.. (CONROY, REBEKAH) (Entered: 05/17/2023) (2) |
| May 17, 2023 | 50 | ANSWER to Complaint , COUNTERCLAIM against MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. by CIPLA LIMITED, CIPLA USA, INC..(TOR, LOLY) (Entered: 05/17/2023) (30) |
| May 17, 2023 | 51 | Corporate Disclosure Statement by CIPLA LIMITED, CIPLA USA, INC. identifying InvaGen Pharmaceuticals, Inc., Cipla (EU Limited), and Cipla Limited as Corporate Parent.. (TOR, LOLY) (Entered: 05/17/2023) (4) |
| May 16, 2023 | 38 | TEXT ORDER: The Court will conduct a telephonic conference on 6/7/2023 at 11:30 A.M., at which time the Court will address whether joinder of the Defendants is appropriate, as well as Plaintiffs' letter submission [D.I. 37]. Counsel shall utilize the following dial-in instructions for the conference call: 1-888-684-8852 / 2828702# / 654321#. SO ORDERED by Magistrate Judge Ann Marie Donio on 5/16/2023. (slc) (Entered: 05/16/2023) (0) |
| May 15, 2023 | 37 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Regarding Status Update re 14 Order. (CALMANN, ARNOLD) (Entered: 05/15/2023) (2) |
| May 12, 2023 | 36 | Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney DMITRY V. SHELHOFF terminated. (SHELHOFF, DMITRY) (Entered: 05/12/2023) (3) |
| May 5, 2023 | 34 | NOTICE of Appearance by MICHAEL RAY DARBEE on behalf of LIFESTAR PHARMA LLC, MANKIND PHARMA LTD. (DARBEE, MICHAEL) (Entered: 05/05/2023) (2) |
| May 5, 2023 | 35 | NOTICE of Appearance by JAY P. LESSLER on behalf of LIFESTAR PHARMA LLC, MANKIND PHARMA LTD. (LESSLER, JAY) (Entered: 05/05/2023) (2) |
| May 3, 2023 | 33 | STIPULATION AND ORDER Dismissing Without Prejudice Defendant Teva Pharmaceutical Industries Ltd. and Amended Caption. The case caption for this Action should be amended to remove Teva Ltd.. Signed by Judge Karen M. Williams on 5/3/2023. (dmr) (Entered: 05/03/2023) (6) |
| May 1, 2023 | 32 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Stipulation and Order Dismissing Without Prejudice Defendant Teva Pharmaceutical Industries Ltd. and Amendment of Caption. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 05/01/2023) (0) |
| Apr 21, 2023 | 30 | SUMMONS Returned Executed by THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P.. TEVA PHARMACEUTICALS, INC. served on 4/20/2023, answer due 5/11/2023. (CALMANN, ARNOLD) (Entered: 04/21/2023) (2) |
| Apr 21, 2023 | 31 | SUMMONS Returned Executed by THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P.. TEVA PHARMACEUTICALS USA, INC. served on 4/20/2023, answer due 5/11/2023. (CALMANN, ARNOLD) (Entered: 04/21/2023) (2) |
| Apr 19, 2023 | 29 | ORDER granting 22 Motion for Leave to Appear Pro Hac Vice as to Elaine Herrmann Blais, Eric. T. Romeo, and Kristin M. Beale. Signed by Magistrate Judge Ann Marie Donio on 4/18/2023. (dmr) (Entered: 04/19/2023) (2) |
| Apr 18, 2023 | 26 | STIPULATION AND ORDER for Waiver of Service of the Complaint and an Extended Answer Deadline for Orbicular Pharmaceutical Technologies Private Limited. Defendant Orbicular shall answer, move, or otherwise respond to the Complaint on or before 5/17/2023. Signed by Magistrate Judge Ann Marie Donio on 4/18/2023. (dmr) (Entered: 04/18/2023) (3) |
| Apr 18, 2023 | 27 | STIPULATION AND ORDER for Waiver of Service of the Complaint and an Extended Answer Deadline for the Cipla Defendants. Defendants Cipla Limited and Cipla USA, Inc. shall answer, move, or otherwise respond to the Complaint on or before 5/17/2023. Signed by Magistrate Judge Ann Marie Donio on 4/18/2023. (dmr) (Entered: 04/18/2023) (3) |
| Apr 18, 2023 | 28 | STIPULATION AND ORDER of Service of the Complaint and an Extended Answer Deadline for the Eugia Defendants. Defendants Eugia Pharma Specialties Ltd., Eugia US LLC, Aurobindo Pharma USA, Inc., and Aurobindo Pharma Limited shall answer, move, or otherwise respond to the Complaint on or before 5/17/2023. Signed by Magistrate Judge Ann Marie Donio on 4/18/2023. (dmr) (Entered: 04/18/2023) (3) |
| Apr 12, 2023 | 25 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Stipulation and Proposed Order for Waiver of Service of the Complaint and an Extended Answer Deadline for Orbicular. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 04/12/2023) (0) |
| Apr 11, 2023 | 23 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Stipulation and Proposed Order for Waiver of Service of the Complaint and an Extended Answer Deadline for the Cipla Defendants. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 04/11/2023) (0) |
| Apr 11, 2023 | 24 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Stipulation and Proposed Order for Waiver of Service of the Complaint and an Extended Answer Deadline for the Eugia Defendants. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 04/11/2023) (0) |
| Mar 31, 2023 | N/A | Set/Reset Deadlines as to 22 MOTION for Leave to Appear Pro Hac Vice . Motion set for 5/1/2023 before Magistrate Judge Ann Marie Donio. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (dmr) (Entered: 03/31/2023) (0) |
| Mar 30, 2023 | 22 | MOTION for Leave to Appear Pro Hac Vice by TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (Attachments: # 1 Certification of Elaine Herrmann Blais, # 2 Certification of Eric. T. Romeo, # 3 Certification of Kristin M. Beale, # 4 Certification of Liza M. Walsh, # 5 Statement in Lieu of Brief, # 6 Text of Proposed Order)(WALSH, LIZA) (Entered: 03/30/2023) (0) |
| Mar 24, 2023 | 21 | STIPULATION AND ORDER Regarding Dismissing Without Prejudice Defendant Lupin Ltd. Amending Caption to Reflect the Same and Personal Jurisdiction, Venue, and Discovery. Signed by Judge Karen M. Williams on 3/24/2023. (dmr) (Entered: 03/24/2023) (5) |
| Mar 22, 2023 | 19 | NOTICE of Appearance by JAMES S. RICHTER on behalf of LUPIN INC., LUPIN LTD., LUPIN PHARMACEUTICALS, INC. (RICHTER, JAMES) (Entered: 03/22/2023) (2) |
| Mar 22, 2023 | 20 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Stipulation and Order. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 03/22/2023) (0) |
| Mar 17, 2023 | 15 | NOTICE of Appearance by LIZA M. WALSH on behalf of TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. (WALSH, LIZA) (Entered: 03/17/2023) (2) |
| Mar 17, 2023 | 16 | NOTICE of Appearance by CHRISTINE INTROMASSO GANNON on behalf of TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. (GANNON, CHRISTINE) (Entered: 03/17/2023) (2) |
| Mar 17, 2023 | 17 | NOTICE of Appearance by JESSICA K. FORMICHELLA on behalf of TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. (FORMICHELLA, JESSICA) (Entered: 03/17/2023) (2) |
| Mar 17, 2023 | 18 | STIPULATION AND ORDER Regarding Dismissing Without Prejudice Defendants Accord Healthcare, Ltd. and Intas Pharmaceuticals. Ltd. Amending Caption to Reflect the Same and Personal Jurisdiction Venue, and Discovery. Signed by Judge Karen M. Williams on 3/17/2023. (dmr) (Entered: 03/17/2023) (6) |
| Mar 16, 2023 | 14 | LETTER ORDER granting Plaintiff's request to adjourn the April 11, 2023 Initial Conference. Signed by Magistrate Judge Ann Marie Donio on 3/16/2023. (dmr) (Entered: 03/16/2023) (2) |
| Mar 15, 2023 | 12 | Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Stipulation and Order. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 03/15/2023) (0) |
| Mar 15, 2023 | 13 | Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Adjournment of Rule 16 Conference and Related Deadlines re 11 Order Initial Scheduling Conference (Camden). (CALMANN, ARNOLD) (Entered: 03/15/2023) (2) |
| Mar 13, 2023 | 11 | Order Initial Conference set for 4/11/2023 at 10:30 AM in Camden - Courtroom 3B before Magistrate Judge Ann Marie Donio. Signed by Magistrate Judge Ann Marie Donio on 3/13/2023. (dmr) (Entered: 03/13/2023) (6) |
| Mar 10, 2023 | 9 | Mankind Pharma Ltd and Lifestar Pharma LLC's ANSWER to Complaint of Theravance Biopharma et al. by MANKIND PHARMA LTD..(SHELHOFF, DMITRY) (Entered: 03/10/2023) (30) |
| Mar 10, 2023 | 10 | Corporate Disclosure Statement by MANKIND PHARMA LTD. identifying Mankind Pharma Ltd. as Corporate Parent.. (SHELHOFF, DMITRY) (Entered: 03/10/2023) (4) |
| Mar 8, 2023 | 7 | NOTICE of Appearance by DMITRY V. SHELHOFF on behalf of MANKIND PHARMA LTD. (SHELHOFF, DMITRY) (Entered: 03/08/2023) (3) |
| Mar 8, 2023 | 8 | NOTICE of Appearance by DMITRY V. SHELHOFF on behalf of LIFESTAR PHARMA LLC (SHELHOFF, DMITRY) (Entered: 03/08/2023) (3) |
| Feb 23, 2023 | 6 | NOTICE of Appearance by KATHERINE ANN ESCANLAR on behalf of MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. (ESCANLAR, KATHERINE) (Entered: 02/23/2023) (2) |
| Feb 17, 2023 | 4 | SUMMONS ISSUED as to ACCORD HEALTHCARE, INC., ACCORD HEALTHCARE, LTD., AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., CIPLA LIMITED, CIPLA USA, INC., EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, INTAS PHARMACEUTICALS LTD., LIFESTAR PHARMA LLC, LUPIN INC., LUPIN LTD., LUPIN PHARMACEUTICALS, INC., MANKIND PHARMA LTD., ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED, TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (ssp, ) (Entered: 02/17/2023) (2) |
| Feb 17, 2023 | N/A | Notice of Judicial Preferences. Click here for the Judge's Individual Procedure Requirements. (ssp, ) (Entered: 02/17/2023) (0) |
| Feb 17, 2023 | 5 | AO120 Patent/Trademark Form filed. (ssp, ) (Entered: 02/17/2023) (1) |
| Feb 16, 2023 | 1 | COMPLAINT against All Defendants ( Filing and Admin fee $ 402 receipt number ANJDC-14046614), filed by THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Civil Cover Sheet)(CALMANN, ARNOLD) (Entered: 02/16/2023) (0) |
| Feb 16, 2023 | 2 | Corporate Disclosure Statement by THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. identifying Theravance Biopharma, Inc. as Corporate Parent.. (CALMANN, ARNOLD) (Entered: 02/16/2023) (3) |
| Feb 16, 2023 | 3 | Corporate Disclosure Statement by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P. identifying Viatris Inc. as Corporate Parent.. (CALMANN, ARNOLD) (Entered: 02/16/2023) (2) |
| Feb 16, 2023 | N/A | Magistrate Judge Ann Marie Donio added. (dmw) (Entered: 02/17/2023) (0) |
